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Abstract
The weaning transition is characterised by morphological, histological and microbial changes, often leading to weaning-associated dis-
orders. These intestinal changes can partly be ascribed to the lack of luminal nutrition arising from the reduced feed intake common in
pigs after weaning. It is increasingly becoming clear that changes in the supply with enteral nutrients may have major impacts on intestinal
gene expression. Furthermore, the major dietary constituents, i.e. carbohydrates, fatty acids and amino acids, participate in the regulation
of intestinal gene expression. However, nutrients may also escape digestion by mammalian enzymes in the upper gastrointestinal tract.
These nutrients can be used by the microflora, resulting in the production of bacterial metabolites, for example, SCFA, which may
affect intestinal gene expression indirectly. The present review provides an insight on possible effects of reduced feed intake on intestinal
gene expression, as it may occur post-weaning. Detailed knowledge on effects of reduced feed intake on intestinal gene expression may
help to understand weaning-associated intestinal dysfunctions and diseases. Examples are given of intestinal genes which may be altered in
their expression due to supply with specific nutrients. In that way, gene expression could be modulated by dietary means, thereby acting as
a potential therapeutic tool. This could be achieved, for example, by influencing genes coding for digestive or absorptive proteins, thus
optimising digestive function and metabolism, but also with regard to immune response, or by influencing proliferative processes, thereby
enhancing mucosal repair. This would be of special interest when designing a diet to overcome weaning-associated problems.
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Introduction
For piglets, the weaning transition from milk to a solid diet
is characterised by a multitude of changes in the intestinal
morphology and function, often accompanied by weaning-
associated disorders(1). The various intestinal changes
associated with weaning can, at least in part, be ascribed
to the distinct lack of luminal nutrition arising as a conse-
quence of reduced feed intake immediately after wean-
ing(2). Furthermore, several studies have shown that
fasting or reduced feed intake may influence intestinal
gene expression; for example, changes in intestinal gene
expression have been reported for brush-border enzymes
and nutrient transporters(3,4), and growth factors(5,6).
Although coordinated alterations of intestinal gene
expression were observed in piglets in response to
weaning(7), it is not always clear whether these changes
are due to the weaning process per se or more related to
associated reductions in feed intake.
Furthermore, specific micro- and macronutrients can
have profound influence on intestinal gene expression,
and, accordingly, on metabolism and on homeostasis(8,9).
The main agents through which nutrients influence gene
expression are the transcription factors, which bind to
specific DNA sequences of genes, thereby activating or
inhibiting their transcription(10) and translating nutritional
stimuli into changes in gene expression(11). For example,
a group of transcription factors, referred to as PPAR, are
sensitive to dietary fatty acids(12), and some of them
(PPAR-g) are involved in the regulation of a number of
inflammatory genes(13,14), thereby leading to attenuation
of inflammation. Thus, it seems to be possible that specific
dietary components may beneficially influence response
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variables related, for example, to immune function and
inflammation. In that way, diet could help to overcome
problems associated to times of multiple stressors, as
they occur, for example, during weaning. The present
review includes two objectives. First, it aims to provide
an insight on possible effects of reduced feed intake on
intestinal gene expression, as it may occur during the
weaning transition. This may help to understand intestinal
dysfunctions and diseases related to the weaning period.
Data from studies focusing on the effect of fasting or
total parental nutrition (TPN) have been included, as
effects of experimental fasting seem to correspond to the
effects of immediate post-weaning anorexia(2,15). Second,
it is hypothesised under which conditions intestinal gene
expression could be modulated by dietary means, thereby
acting as a potential therapeutic tool. Therefore, examples
are given of intestinal genes which may be altered in their
expression as a consequence of supply with specific diet-
ary nutrients, including carbohydrates, fats and proteins/
amino acids. Reference is also made to studies investigating
the effect of microbial fermentation metabolites on intesti-
nal gene expression, as some of them, for example,
SCFA(16,17), have been shown to affect gene expression(18).
As manipulation of the diet may be an appropriate way of
changing the composition and activity of the gastrointesti-
nal microflora(19,20), this would open further perspectives
to indirectly affect intestinal gene expression. The present
review includes mainly data from pigs and rodents, but,
if applicable, also from other species.
The weaning transition: a brief summary
For piglets, weaning involves complex psychological,
social, environmental and dietary stresses that interfere
with intestinal development and adaptation (Table 1).
The immediate effect of weaning is a dramatic reduction
in feed (energy) intake for up to 2 or 3 d(1) leading to
undernutrition and a transient growth check(21). This tem-
porary weaning anorexia results in alterations of intestinal
integrity and appears to be one of the major aetiological
factors in gut-associated disorders(15,22,23). Intestinal altera-
tions often seen in piglets post-weaning include changes in
villus–crypt architecture and in activities of many brush-
border digestive enzymes. For example, marked villus atro-
phy (245 to 270 % of pre-weaning values), particularly in
the proximal small intestine, has been repeatedly reported
during the degenerative phase(15,23). Also, a reduction of
lactase activity followed by increased maltase and sucrase
activities immediately post-weaning have been consistently
reported and may reflect maturation of intestinal function
in relation to the weaning diet(15). These changes are
thought to temporarily decrease the digestive and absorp-
tive capacity of the small intestine. Furthermore, the transi-
ent alteration of intestinal integrity is characterised by
increased mucosal permeability, and disturbed absorp-
tive-secretory balance(24), probably also related to the
weaning-associated fasting period imposed on pig-
lets(25,26). In addition, a stimulation of pro-inflammatory
cytokine gene expression in piglets post-weaning has
also been reported(27). The pro-inflammatory cytokines
IL-1b, IL-6 and TNF-a represent early non-specific
mediators of inflammation, and are known to affect intesti-
nal epithelial permeability and transport(1,28). Furthermore,
increased T cell numbers and increased local expression of
the matrix metalloproteinase stromelysin in the small intes-
tine have been measured during post-weaning anorexia in
piglets, and may contribute to intestinal inflammation(2). In
addition, the transition from milk to a solid diet leads to
dramatic changes in the composition of the microbial
population of the gastrointestinal tract (GIT) during the
7–14 d after weaning(29). According to Ewing & Cole(30),
numbers of lactobacilli and other beneficial bacteria
decrease in times of stress, as do their beneficial effects.
This allows potential pathogens such as coliforms to
increase. Franklin et al.(31) found that lactobacilli popu-
lations in different GIT sections (jejunum, ileum, caecum)
declined to lower levels in early-weaned pigs (17 d), com-
pared with pigs weaned at 24 d. Accordingly, Janczyk
et al.(32) found dramatic changes in the diversity of lactoba-
cilli populations in the ileum around weaning. According
to Konstantinov et al.(33), two Lactobacillus species domi-
nate in ileal samples of neonatal and unweaned piglets,
but following weaning, these two lactobacilli significantly
declined in numbers. Such weaning-associated changes
Table 1. Weaning transition in young pigs (adapted from Lalle`s et al.(1))
Immature animal for Behaviour
Intestinal function (secretions, motility, digestion, absorption, defence, etc.)
Immune system
Stress Psychological: separation from mother; mixing with other litters; new environment
Alterations in intestinal
architecture and function
Dietary: withdrawal of milk; access to dry feed
Morphology: villous atrophy followed by crypt hyperplasia
Reduced activities of intestinal digestive enzymes
Disturbed intestinal absorption, secretion and permeability
Disturbed microbial ecology and associated enteric pathogens (for example, Escherichia coli, rotavirus, etc.)
Main risk factors Dietary: low feed intake; antinutritional factors; diets with high component complexity and low digestibility;
high protein level (þhigh buffering capacity)
Rearing: large litter size and low weaning weight; high density of piglets post-weaning; low level of hygiene;
inadapted environment (low temperature, low air quality, etc.)

















in the intestinal microbiota can, in turn, also influence
immune development(34). However, the molecular mech-
anisms underlying weaning anorexia and refeeding are
not well established in piglets(35). Recent studies which
used microarray techniques have shown that weaning in
piglets coincides with marked alterations in the expression
of various intestinal genes, related to nutrient metabolism
and/or cell proliferation and/or immune function(7,36).
Such information would be relevant for improving the
understanding of post-weaning gut disorders(35).
Changes in intestinal gene expression due to reduced
feed intake
Digestive function and nutrient metabolism
Several studies with rodents have investigated effects of
changes in the nutritional status on intestinal gene
expression, for example, of intestinal nutrient transporters.
For example, short-term starvation in rats leads to a sub-
stantial increase in mRNA levels of the monosaccharide
carrier by which fructose is absorbed (GLUT5)(37). Other
nutrient transporters that are sensitive to alterations of the
nutritional status are the oligopeptide transporters, such
as the Hþ-dependent peptide transporter-1 (Pept1),
which is responsible for absorption of the products of pro-
tein digestion from the intestinal lumen into the epithelial
cell such as dipeptides and tripeptides(38). It is accepted
that Pept1 gene regulation is, amongst other factors, regu-
lated by the diet(39). Short-term starvation over a period of
1 or 4 d in rats increases dipeptide absorption rates, paral-
leled by increases in Pept1 protein and mRNA levels(40,41).
Similarly, increases in Pept1 mRNA levels were observed
for rats which received 7 d TPN(42). This was also observed
after 10 d of TPN, and an increased Pept1 protein density
was noted(3). Consequently, fasting, both during short-
term or prolonged periods, increases the Pept1 mRNA
level, resulting in an increase in the population of the
transporter in the brush-border membrane of the intestinal
mucosa(43). Increased expression and activity of Pept1
during feed deprivation or restriction may serve as a mech-
anism to compensate for a reduced mucosal surface
area(39). According to Barbot et al.(44), the physiological
significance of increased expression is to counterbalance
the shortening of the absorptive surface during starvation.
The latter can be even more important when there is an
infection. For example, an enhanced level of Pept1
mRNA was found in suckling rats during acute cryptospor-
idiosis. This is an infection with Cryptosporidium parvum
which frequently results in diarrhoea(44). The authors
suggested that this transcriptional up-regulation plays an
important role in the adaptation to malnutrition associated
with cryptospiridiosis. Although the study of Barbot
et al.(44) was performed with rats, one could also imagine
a similar mechanism for pigs, to overcome malnutrition
associated with diarrhoea. A mechanism for this induction
of intestinal Pept1 during fasting was proposed by
Shimakura et al.(45). They demonstrated in rats that the
fasting-induced up-regulation of Pept1 expression is
mediated via PPAR-a, a member of a family of ligand-
activated nuclear receptors. The nuclear receptors are
one of the largest groups of transcription factors, and are
the most important group of nutrient sensors(10,46,47).
PPAR-a is an important mediator of the hepatic response
to fasting, and is believed to be a major regulator of lipid
and glucose metabolism, allowing adaptation to the
prevailing nutritional environment(48–50). Shimakura
et al.(45) hypothesised that increased Pept1 minimises the
loss of N by efficient absorption of small-intestinal peptides
derived from sloughing cells or secreted hormones.
Furthermore, such an induction of Pept1 expression
might be a preparation for adaptation when food is given
again after fasting.
Also, the gene expression of intestinal transporters and
phase I/II metabolic enzymes, which are required for ade-
quate metabolism and excretion of various endogenous
molecules, nutrients and xenobiotics, is affected by fast-
ing(51,52). According to a study of Van den Bosch et al.(52)
in the murine small intestine, 24 h of fasting resulted in
the up-regulation of genes, for example, involved in the
transport of energy-yielding molecules during glycogen-
olysis and during mitochondrial and peroxisomal oxidation
of fatty acids. As some of the transporters and phase I and
II genes are regulated in dependency of PPAR-a, it appears
that the absorptive and detoxification capacity of the small
intestine is altered during fasting, and PPAR-a mediates a
part of these alterations(52).
Le Hue¨rou-Luron et al.(53) studied in piglets small-intes-
tinal changes due to weaning and found that a post-wean-
ing increase of maltase activity paralleled that of maltase
mRNA. In their study, maltase mRNA abundance and
activity were 2·3-fold higher in 25 d weaned control than
in 18 d-suckled piglets. Marion et al.(54) investigated the
effect of feed intake level after weaning on the activity of
several brush-border enzymes and mRNA levels in early-
weaned piglets (aged 7 d). In their study, however, only
maltase showed weaning-induced increases in activity,
which were closely correlated with corresponding mRNA
levels. This suggests a mainly transcriptional regulation of
maltase in response to weaning. However, changes in
specific activities of brush-border enzymes during weaning
may also reflect indirect effects resulting from a lower feed
intake. Indeed, the most striking consequence of post-
weaning anorexia is a rapid mucosal atrophy of the small
intestine, associated with a reduction of villous height
and increases in crypt depth which are generally associated
with reductions in the specific activities of the brush-border
enzymes lactase and sucrase(15,55). Alterations of intestinal
integrity, however, were also observed in underfed piglets
and piglets receiving TPN, when compared with their
counterparts being fed ad libitum or receiving enteral
nutrition, independently of the weaning process(26,56).

















Mazurais et al.(35) investigated the impact of fasting and
refeeding on the piglet’s jejunal transcriptome during the
weaning period. In their study, 21-d-old sow-reared piglets
were fasted for 2 d before slaughtering at the age of 23 d.
Porcine arrays associated with real-time PCR were used
to assess global gene expression changes in the jejunum
of piglets at weaning. In this study, some genes associated
with carbohydrate and lipid metabolism (6-phosphofructo-
kinase, pyruvate kinase, triosephosphate isomerase, apoA-
IV) were down-expressed in fasted and refed animals,
while other genes involved in carbohydrate metabolism,
for example, a member of carbonyl-reducing enzymes
(short-chain dehydrogenase/reductase (SDR) family
member 4)(57), were up-expressed in fasted piglets. The
authors concluded from their study a major impact of
weaning on the jejunal transcriptome. Although a direct
correlation between transcriptomic regulation and func-
tional impact is not always clearly to establish, more
information on the underlying mechanisms of weaning-
associated anorexia and subsequent refeeding would be
needed for better understanding of weaning-associated
gut disorders. Also, Wang et al.(7) studied a wide range
of genes by using microarray technology. They showed
that early weaning in piglets coincides with a modulation
of small-intestinal expression of several genes. In this
study, feed intake was reduced by 36 % in weaned piglets
as compared with suckling piglets. Reduced expression
was shown in pigs aged 28 d weaned at age 21 d in com-
parison with age-matched suckling piglets, amongst
others, for genes encoding for proteins related to protein
and peptide degradation (for example, aminopeptidase
A, cathepsin F), lipid metabolism (for example, acyl-CoA
dehydrogenase, carnitine transporter 2) and intestinal
transport (for example, apoA-IV precursor, fatty acid-
binding protein, sodium- and chloride-dependent creatine
transporter I). Down-regulation of these genes is expected
to reduce intestinal transport and utilisation of dietary
nutrients (particularly lipids and proteins). Other genes of
lipid metabolism (for example, hydroxymethylglutaryl-
CoA synthase, squalene epoxidase), but also of carbo-
hydrate metabolism (galactoside 2-a-L-fucosyltransferase),
showed enhanced expression. The authors concluded
that early weaning would result in a decreased expression
of genes related to nutrient utilisation.
Immune function
Wildhaber et al.(58) investigated the effect of completely
reduced enteral nutrition on the function of intra-epithelial
lymphocytes (IEL), as measured by IEL cytokine mRNA
expression in mice. In this study, TPN-mice showed a
decline in IL-2 and IL-10 expression, while IL-4, IL-6, inter-
feron (IFN)-g, transforming growth factor (TGF)-b1 and
TNF-a were increased, as compared with mice receiving
oral feeding, or receiving TPN plus oral feeding. This
suggests that the lack of enteral nutrition is responsible
for changes in intestinal immune function caused by
TPN, and not the administration of the TPN solution
itself. Alterations of IEL cytokine mRNA expression (for
example, an increased IFN-g mRNA expression) have
also been shown by Kiristioglu & Teitelbaum(59) in mice
receiving TPN. Changes in the expression of IEL-derived
cytokines, particularly an up-regulation of IFN-g
expression, may be associated with a loss of epithelial bar-
rier function in mice(60). This may contribute to problems
often associated with TPN, such as an increased rate of
bacterial translocation(61). For the young animal, this
would provide a link between weaning-associated anor-
exia, i.e. lack of luminal nutrition, and an enhanced sus-
ceptibility to intestinal infections observed during this
period. A modified epithelial barrier function has also
been observed in piglets resulting from weaning-associated
anorexia, and might allow the passage of pathogens poss-
ibly leading to diarrhoea(1,24). Additionally, Fukatsu et al.(62)
showed a decrease in IL-4 and IL-10 mRNA expression in
lamina propria cells of mice receiving TPN compared
with mice fed normal chow. These immunoregulatory
cytokines are known as IgA-stimulating cytokines. As IgA
is a critical component in mucosal immunity and barrier
integrity, a decrease in expression of these cytokines
would explain impaired mucosal immunity associated
with the lack of enteral feeding(62,63).
The process of weaning is associated with large differ-
ences in the number of genes expressed in the jejunal
mucosa of piglets directly after weaning (aged 4 weeks)
in comparison with older pigs (aged 12 weeks). The
most notable contrast was the high number of immune-
associated genes expressed in 4-week-old animals(36).
Furthermore, Wang et al.(7) observed that early weaning
modulated the expression of several genes in the small
intestine of piglets (as compared with suckling piglets),
mostly with an increased expression of genes that promote
oxidative defence and immune activation. For example,
enhanced expression was observed for genes responsible
for immune function, for example, Iga chain C, Igk chain
C, Igl chain and IgJ chain. These belong to polypeptide
chains composing an antibody molecule. Also enhanced
expression was shown for polymeric Ig receptor precursor
and for lysozyme. The polymeric Ig receptor is a cell sur-
face receptor of mucosal epithelial cells that mediates the
transport of IgA and IgM through the epithelial cells into
the intestinal lumen, where they function as inhibitors of
bacterial/viral adherence and penetration of the underlying
epithelium(64), while lysozyme is an antimicrobial pro-
tein(65). An increased expression of glutathione transferase
v-1 could also be seen, suggesting the presence of oxi-
dative stress in the small intestine of weaned piglets(7,66).
Indeed, intestinal oxidative stress has been associated
with the initiation and propagation of intestinal pathol-
ogies, for example, ischaemic-reperfusion disorders(67,68)
for which intestinal lesions have been shown for newborn
piglets similar to those seen in human newborns with

















necrotising enterocolitis(69,70). Furthermore, in piglets the
pattern of pro-inflammatory cytokine gene expression in
the intestine changes throughout weaning (weaned age
28 d), with an up-regulation of IL-1b, IL-6 and TNF-a
mRNA during the first 2 d post-weaning. After 2 d post-wean-
ing, the mRNA level of these cytokines returned to pre-wean-
ing levels, with the exception of TNF-a mRNA level in the
distal small intestine, which remained high(27). The cytokine
IL-1b can be up-regulated in response to a wide range of
specific and non-specific stimuli. In the study of Pie´
et al.(27), IL-1b expression increased in all segments investi-
gated, suggesting that its up-regulation seems to be more
related to the general stress associated with weaning rather
than to a specific stimulation. Accordingly, in rats an initial
increase of IL-1b expression in Peyer’s patches was found
at 19 d, and a further elevation at 21 d of age (the time of
weaning), suggesting that this cytokine is involved in the
differentiation and/or activation of epithelial cells at wean-
ing(71,72). TNF-a, on the other hand, appears to be involved
in the stimulation of Cl2 secretion into the ileum(73),
suggesting that an increased expression of TNF-a might be
implicated in the development of diarrhoea. Such early
gene up-regulation of pro-inflammatory cytokines associ-
ated with weaning may contribute to early functional dis-
orders, favouring the development of diarrhoea(27). In a
further study of Pie´ et al.(74), the effect of enforced fasting
(48 h) on mRNA content of pro-inflammatory cytokines in
the ileum and colon of newly weaned piglets was investi-
gated, and no correlation between the quantity of feed
intake and the mRNA content of the pro-inflammatory
cytokines IL-1b, IL-6 and TNF-a could be observed at day
4 post-weaning. Other studies, however, reported that a
lack of intestinal nutrient provision (i.e. parenteral feeding)
favours the development of inflammation in the intestine
of piglets(75,76).
Growth factors
Several nutrient-regulated intestinal growth factors, such
as insulin-like growth factor (IGF)-I, are associated with
fasting-induced atrophy and refeeding-induced intestinal
regrowth(77). Moreover, the administration of exogenous
IGF-I has been noted to reverse the mucosal atrophy
induced by TPN in rodents(78). The IGF promote the
proliferation and differentiation of cells in various organ
systems, including intestinal epithelial cells(79). Their
biological actions are mediated by binding to specific cell
surface receptors(80,81), and are directly regulated by IGF-
binding proteins (IGFBP)(79,82,83). The IGF system, including
IGF-I, IGF-II, the IGFBP and the IGF membrane-associated
receptors, is highly sensitive to nutritional status(84). In
Table 2, some studies are summarised describing the
effects of fasting/refeeding on growth factors. For example,
fasting in rats decreased jejunal IGF-I mRNA levels and
plasma IGF-I concentrations and induced intestinal
atrophy(5). These changes were reversed by refeeding.
However, levels of IGF-I receptor and IGF-I receptor
mRNA were not significantly altered during fasting, but
they increased after refeeding. Such up-regulation of IGF-I
and IGF-I receptor expression during refeeding suggests
a role for the IGF action pathway in gut trophic responses
to enteral nutrients. Other growth factor systems, such as
the keratinocyte growth factor (KGF), stimulate, amongst
others, the proliferation of intestinal epithelial cells(85,86),
and are also regulated by the nutritional status of the
animal(87). However, in contrast to intestinal IGF-I and
IGF-I receptor mRNA(5), intestinal KGF and KGF receptor
mRNA levels were up-regulated during fasting, and
returned towards control values after ad libitum refeeding.
The increase in KGF and KGF receptor mRNA may be an
adaptive response to maintain intestinal cell proliferation
during starvation, when the expression and action
of other growth factor systems, i.e. IGF-I, are blunted(87).
Furthermore, it has been shown that the gene expression
of several IGFBP changes in response to weaning. Different
IGFBP show different patterns during postnatal develop-
ment in the rat(88) and also in the pig(89). Such changes in
the expression of the intestinal IGF system may be important
for intestinal adaptive growth of the small-intestinal mucosa
Table 2. Changes in intestinal gene expression due to fasting/refeeding in rats: effect on growth factors
Treatment Effect Reference
Fasting, 72 h Jejunal IGF-I mRNA, plasma IGF-I concentration # 5
Intestinal atrophy "
IGF-I receptor, IGF-I receptor mRNA –
Refeeding Changes reversed
IGF-I receptor, IGF-I receptor mRNA "
Fasting, 72 h Ileal KGF, KGF receptor mRNA " 87
Colonic KGF receptor mRNA "
Refeeding, ad libitum, 72 h Return to control levels
Fasting, 72 h Jejunal proglucagon mRNA # 6
Refeeding Return to control levels
Fasting, 48 h Plasma IGF-I and GLP-2, jejunal mucosal cellularity (mass, protein, DNA, villous height),
jejunal IGF-I mRNA, ileal proglucagon mRNA #
95
Refeeding, intragastric and ad libitum Plasma GLP-2, jejunal IGF-I mRNA " , mucosal regrowth
IGF, insulin-like growth factor; # , decrease; " , increase; –, no effect; KGF, keratinocyte growth factor; GLP, glucagon-like peptide.

















in response to weaning for protection against mucosal
damage during, for example, inflammation(89).
Glucagon-like peptides (GLP) represent the major
secretory peptides derived from the post-translational pro-
cessing of the proglucagon gene(90,91). GLP-2 plays an
essential role in maintaining the intestinal structure in the
fed state, but also during adaptation in response to nutrient
deprivation and subsequent feeding(92). For young dom-
estic animals, a potential therapeutic application of GLP-2
was suggested in periods of intestinal dysfunction and
damage, such as during weaning and diarrhoeal dis-
eases(93). Intestinal expression of proglucagon mRNA is
influenced by the nutritional status of the animal. For
example, in rats(6) and mice(94), fasting is associated with
a decrease in intestinal proglucagon mRNA expression,
while refeeding rapidly increases levels back to those of
normal non-fasted controls (Table 2). Furthermore, in a
study of Nelson et al.(95) (Table 2), fasting in rats signifi-
cantly decreased plasma concentrations of IGF-I and
GLP-2, jejunal mucosal cellularity, IGF-I mRNA and ileal
proglucagon mRNA. Upon intragastric and ad libitum
refeeding, levels of plasma GLP-2 and jejunal IGF-I
mRNA were elevated, accompanied by mucosal regrowth.
This suggests that luminal nutrients stimulate intestinal
growth, partly by an increased expression of both GLP-2
and IGF-I(95). Furthermore, Petersen et al.(96) found that
enteral food supply decreased small-intestinal GLP-2
receptor mRNA abundance (which was highest at birth)
in suckling and weaned pigs. The authors suggest that
introduction of enteral feeding transiently increases
plasma GLP-2 concentrations and decreases the levels of
small-intestinal GLP-2 receptor mRNA during pig develop-
ment. This emphasises the role of GLP-2 in the growth of
the small intestine around birth and weaning due to a
response to enteral nutrition.
Influence of dietary components on intestinal gene
expression
Diet is a potent stimulant for altering the environment of
cells in most organs, particularly in the GIT. A normal
diet mainly consists of different proportions of carbo-
hydrates, proteins and lipids, which may, along with vita-
mins and minerals, exert individual effects on intestinal
gene expression(47). In the following, examples are given
where the major dietary constituents, i.e. carbohydrates,
lipids and proteins/amino acids have been shown to
affect intestinal gene expression. Besides, nutrients may
escape digestion by mammalian enzymes in the small
intestine. When present in the large-intestinal lumen, this
material undergoes intense degradation by the colonic
microflora resulting in the release of numerous bacterial
metabolites. Fermentation of, for example, carbohydrates
results, amongst others, in the production of SCFA(97).
With regard to SCFA, especially butyrate has been shown
to have multiple effects on cultured mammalian cells that
include inhibition of proliferation, induction of differen-
tiation and induction or repression of gene expression(18).
However, other microbial metabolites also are able to influ-
ence intestinal gene expression. For example, polyamines,
which originate, amongst others, from microbial proteol-
ysis(97), but also from dietary sources, have been shown
to modulate the expression of various genes involved
in, for example, cell proliferation(98,99) or apoptosis(100).
Polyamines are required for the stimulation of mucosal
growth, in part, through their ability to regulate the
expression of nuclear transcription factors(99,101,102). Thus,
in the following, reference will also be made to studies
focusing on intestinal gene expression as mediated by
bacterial metabolites.
Protein and amino acids
Digestive function and nutrient metabolism. Typically,
specific dietary components can affect the activity and
gene expression of digestive enzymes and transporters.
For example, the expression of the oligopeptide transpor-
ter Pept1 varies according to diet composition. In rats, a
high-protein diet (50 %) resulted in a two-fold increase of
Pept1 mRNA levels as compared with animals fed a low-
protein diet (4 %)(103) or a protein-free diet(104). In the
study of Shiraga et al.(104), rats were fed a diet sup-
plemented with a single dipeptide (Gly-Phe) and phenyl-
alanine for 3 d. The dipeptide and the amino acid
enhanced transport activity, which was accompanied by
an increase in Pept1 mRNA and protein in intestinal muco-
sal cells. Also, treatment of human intestinal cells with the
dipeptide glycyl–sarcosine resulted in an increased Pept1
mRNA abundance, enhanced transport rate of the dipep-
tide glycyl–glutamine(105) and vice versa(106). In con-
clusion, endproducts of protein digestion, for example,
small peptides, seem to participate in pathways that control
the expression of intestinal transporters such as Pept1. This
may lead to increased transporter capacity in the digestive
tract(107), and results in an increased peptide transport, a
characteristic of intestinal adaptation to a high-protein
diet(43,108). Although a practical use of peptides in livestock
nutrition is still lacking, results of these studies suggest
better nutritional management. Providing a diet that best
accommodates the profile of digestive enzymes and nutri-
ent transporters in the gut will result in improved nutrient
utilisation of dietary protein, reduced N excretion,
improved health and growth of the animal(39).
Furthermore, the intestinal peptide transport system is
important for animals during the suckling period(109). For
example, Pept1 mRNA levels in the small intestine of rats
increased rapidly from the early days to the middle of
the suckling period, and then decreased from the middle
to the end of the suckling period(110). According to a
study of Wang et al.(111), Pept1 mRNA expression in the
duodenum, proximal and distal jejunum of Tibetan piglets
gradually increased from day 1 to the middle of the

















suckling period, and then gradually decreased from the
middle to the end of the suckling period. The authors con-
cluded that Pept1 gene expression was up-regulated by the
onset of suckling colostrum or milk, which is rich in nutri-
ents and growth factors, and thus the transport activity of
the entire small intestine increased due to a dramatic
increase in intestinal mucosal mass. However, from the
middle to the end of the suckling period, the nutrients
ingested by the piglets were limited by the milk yield of
the sow, resulting in a decreased transport activity of the
entire small intestine. Obviously, Pept1 mRNA expression
along the small intestine is regulated according to age in
early development, which may have major implications
for amino acid and protein nutrition in young animals.
Dietary glutamine supplementation improves, amongst
others, nutrient digestion and nutrient utilisation in early-
weaned piglets(112). Wang et al.(7) showed, in response to
dietary glutamine supplementation to piglets weaned on
d 21, effects on small-intestinal gene expression that
would provide an idea for the beneficial effects of gluta-
mine. By using microarray technology, Wang et al.(7)
found, for example, an increased expression of genes
related to lipid metabolism, Fe absorption and regulation
of nutrient metabolism. For example, an increased
expression was found for endozepine, which is expressed
in intestinal mucosal cells, and which, amongst other func-
tions, acts like acyl CoA-binding protein, thus regulating
lipid metabolism, assembly and trafficking across the
small intestine(113,114). Furthermore, an enhanced gene
expression was observed for IL-13R-a-1, which is part of
a receptor binding IL-13. The cytokine IL-13 stimulates
contractility of intestinal smooth muscle, thereby promot-
ing gut motility(115). This may support the movement of
luminal digesta along the small intestine, thereby facilitat-
ing the digestion of macronutrients by digestive enzymes
and absorption of the resulting smaller molecules by enter-
ocytes. However, on the other hand, an increase in intesti-
nal motility also may cause excessive fluid losses, due to an
increased transit time(116), which would then rather be a
negative effect.
Immune function. In the study of Wang et al.(7) with
piglets weaned on day 21, the small-intestinal expression
of several genes was down-regulated in response to dietary
glutamine, including genes related to immune activation.
However, there was an increased expression of genes
related to defence against infection, such as IL-13R-a-1,
and endozepine. Porcine endozepine has been shown to
exert a potent antibacterial activity in the porcine gut(117),
while IL-13 is a multi-functional cytokine involved in host
defence against infection, for example, against protozo-
ans(118). As early weaning is often associated with immuno-
logical challenges in the intestine(119), elevated expression
of, for example, endozepine in glutamine-supplemented
diets for piglets may thus protect the gut from infections
during weaning. Altogether, this study(7) provides evidence
for a possible molecular mechanism which would explain
previous findings according to which dietary glutamine
supplementation prevents intestinal dysfunction and
enhances growth performance of early-weaned piglets(112).
Arginine is a non-essential amino acid that has attracted
interest because it plays an important role in many physio-
logical and biological processes including physiology of
the GIT(120). It has been shown to be effective in a
number of gut injury models(121,122). In a study of Liu
et al.(123), dietary arginine supplementation alleviated intes-
tinal mucosal disruption induced by Escherichia coli lipo-
polysaccharide (LPS) in weaned pigs. In this study, 0·5 %
arginine prevented the elevation of jejunal and ileal TNF-a
mRNA abundance, and 1·0 % arginine alleviated the
elevation of jejunal IL-6 mRNA and TNF-a mRNA abun-
dance induced by LPS challenge. There was also a ten-
dency for increased PPAR-g mRNA abundance in the
duodenum, jejunum (P,0·05) and ileum due to arginine
supplementation. These results indicate that arginine sup-
plementation has beneficial effects in alleviating gut muco-
sal injury induced by LPS challenge, possibly by decreasing
the expression of intestinal pro-inflammatory cytokines
through activating PPAR-g expression. PPAR-g is a tran-
scription factor and has been recognised as an endogenous
regulator of intestinal inflammation(124). PPAR-g ligands
have been shown to be effective in intestinal inflammatory
models(125). The protective effects of PPAR-g and its
ligands are associated with the inhibition of inflammatory
indices such as pro-inflammatory cytokines(126). The
inhibitory effect of PPAR-g on pro-inflammatory cytokines
could be mediated through the inhibition of transcription
factor NF-kB(127,128).
Lipids
Digestive function and nutrient metabolism. Lipids of
dietary origin can be involved in the regulation of
expression of genes related to digestion and nutrient trans-
port. For example, in a study of Yasutake et al.(129),
6-week-old rats were fed either a diet high in medium-
chain TAG (MCT), a diet high in long-chain TAG or a high-
carbohydrate diet. As compared with the long-chain TAG
diet, the MCT diet as well as the carbohydrate diet resulted
in jejunal elevation of mRNA of sucrase–isomaltase, and of
Na-coupled glucose co-transporter-1 (SGLT1), by which
glucose enters the epithelial cells via active transport(130).
Force-feeding the MCT or a high-sucrose diet evoked a
marked increase in sucrase–isomaltase mRNA and SGLT1
mRNA levels within 12 h, as compared with force-feeding
a long-chain TAG diet. This suggests that not only carbo-
hydrate intake but also MCT intake might influence jejunal
sucrase–isomaltase mRNA and SGLT1 mRNA levels, prob-
ably through a generation of common metabolite(s) of
carbohydrates and MCT(129). According to the study of
Yasutake et al.(129), glycerol as such a metabolite originating
from MCT might enter the glycolytic pathway and mimic
the effect of a high-carbohydrate diet.

















Furthermore, the high lipid content of mother’s milk
might play a role in intestinal gene expression of newborn
animals. For example, in neonatal piglets given a high-TAG
intraduodenal infusion for 24 h, jejunal apoA-IV expression
increases 7-fold at the pretranslational level in comparison
with control animals given a low-TAG infusion(131,132).
ApoA-IV is expressed in the small intestine and plays a
role in lipid absorption, transport and metabolism(133). In
the older, suckling piglet, only a two-fold increase could
be shown. This might be of importance in the newborn
receiving a high-fat milk diet, when apoA-IV may play a
role in facilitating enterocyte lipid transport under such
conditions of high lipid flux(134). More recently, it has
been shown in developing rats(135) that fatty acids in
mother’s milk induce gene expression of the liver-type
fatty acid-binding protein (L-FABP) and cellular retinol-
binding protein type II (CRBPII), which are cytosolic bind-
ing proteins for fatty acids and vitamin A, facilitating their
absorption from lumen to the enterocytes. In this study,
jejunal mRNA levels of PPAR-a were increased during the
suckling period. Furthermore, the authors examined the
expression of these genes following oral administration
of a range of fatty acids, namely caprylic acid, oleic acid,
linoleic acid and arachidonic acid, all of which are com-
ponents of the milk of weaning rats. PPAR-a, L-FABP and
CRBPII were induced by caprylic and oleic acids to similar
extents. The results of this study indicate that the
expression of small-intestinal L-FABP and CRBPII genes
in postnatal development is regulated by a change in
expression of PPAR-a which transmits the signalling of
fatty acids derived from milk(135). For the young animal,
this suggests that fatty acids in milk may help to ensure
the effective absorption of dietary fat and vitamin A.
Immune function. Several studies have been per-
formed investigating the effects of dietary lipids on intesti-
nal gene expression with regard to immunological
parameters, mostly directed to intestinal inflammation.
According to a study with rats(136), MCT enhanced
secretory IgA (sIgA) expression in the ileum compared
with rats given maize oil. After LPS challenge, expression
of sIgA was decreased in the maize oil group but not in
the MCT group. Furthermore, MCT administration resulted
in a decreased expression of pro-inflammatory cytokines
(TNF-a and IL-18), and an increased expression of IgA-pro-
moting cytokines (IL-6, IL-10), together with lower mRNA
expression of the IgA-inhibiting cytokine IFN-g. Since
sIgA plays an important role in protection against infec-
tions in the intestinal immune system, an enhanced sIgA
production is thought to be beneficial for the organism(137).
Obviously, dietary MCT can reduce intestinal injury after
endotoxin administration by inhibition of the expression
of some inflammatory cytokines and enhancing intestinal
sIgA(136).
Furthermore, effects on intestinal gene expression have
been shown in several studies investigating the anti-inflam-
matory effects of dietary conjugated linoleic acid (CLA)
(Table 3). Hontecillas et al.(138) could show in pigs with
induced colitis that supplementation with CLA before the
induction of colitis decreased mucosal damage and main-
tained cytokine expression and lymphocyte subset distri-
bution similar to that in non-infected pigs. Furthermore,
CLA supplementation led to an enhanced colonic
expression of PPAR-g. Accordingly, Bassaganya-Riera
et al.(139) found amelioration of colitis in mice due to
CLA-supplemented diets, mediated through a PPAR-g-
dependent mechanism. PPAR-g belongs to a group of tran-
scription factors that are sensitive to dietary fatty acids(12),
and thus may translate nutritional stimuli into changes in
gene expression(11). Activators of PPAR-g have been
shown to inhibit the activation of a number of inflamma-
tory genes(13,14). The anti-inflammatory actions of PPAR
may occur via stimulation of the breakdown of inflamma-
tory eicosanoids through the induction of peroxisomal
b-oxidation(140,141). However, they may also interfere
with or antagonise the activation of other transcription
factors, including NF-kB(142), thereby suppressing the
expression of pro-inflammatory cytokines (i.e. TNF-a, IL-6
and IL-1b)(128). In a further study of Bassaganya-Riera &
Hontecillas(143), using a pig model with induced colitis,
dietary CLA supplementation up-regulated colonic PPAR-g
expression and contributed to a delay in the onset of
induced colitis and an attenuated growth depression in
Table 3. Effect of dietary conjugated linoleic acid supplementation on gene expression related to immune function in pigs
Weight and age of pigs, tissue, challenge Effect Reference
Pigs, 4.8–5.5 kg, bacterial-induced colitis Cytokine expression (IL-10, IFN-g), lymphocyte subset distribution
(CD4þ, CD8þ) similar to non-infected pigs
138
Mucosal damage #
Colonic expression of PPAR-g "
Pigs, 15 d old, induced colitis TNF-a # 143
Growth depression #
Delayed onset of colitis
Colonic expression of PPAR-g "
Pigs, 7.8–8.3 kg, spleen and thymus,
challenged with LPS
IL-6 mRNA, TNF-a mRNA # 144
IL-10 mRNA "
PPARg mRNA "
IFN, interferon; # , decrease; " , increase; LPS, lipopolysaccharides.

















the pigs, coupled with down-regulation of TNF-a. Simi-
larly, Changhua et al.(144) found that dietary CLA attenuated
the production and expression of pro-inflammatory cyto-
kines in the spleen and thymus of weaned pigs challenged
with LPS, mediated at least in part through a PPAR-g-
dependent mechanism, together with an enhanced pro-
duction and expression of the anti-inflammatory cytokine
IL-10. These studies suggest the potential of dietary CLA
in alleviating mucosal damage originating from intestinal
inflammation, thereby possibly improving overall gut
health.
Carbohydrates
Digestive function and nutrient metabolism. Many
studies have shown that feeding a high-carbohydrate diet
induces the intestinal expression of genes related to carbo-
hydrate digestion and absorption, including disacchari-
dases and monosaccharide transporters(145,146). For
example, upon the introduction of a high-starch diet to
rats, both sucrase and lactase activities were elevated,
accompanied by the accumulation of the respective
mRNA(129,147). Also, expression of the SGLT1 gene is up-
regulated by feeding rodents a carbohydrate-rich
diet(129,146). Furthermore, dietary fructose (or a metabolite
of it) leads to an increase in the transcripts of sucrase–
isomaltase and lactase genes in rats, as well as for the
transcripts of the transporter (GLUT5) genes(145,146). Thus,
transcriptional regulation is involved in the dietary adap-
tation of the carbohydrate digestion/absorption-related
genes, and regulation of enzymes and transporters seems
to be linked to each other(148). However, according to a
study of Cui et al.(149), using microarray hybridisation and
relative quantitative reverse transcription-PCR, a wide
range of genes changed in their expression in response
to a fructose perfusion of the rat small intestine. Along
with expression of the intestinal brush-border fructose
transporter GLUT5, expression of more than twenty
genes increased considerably, including two gluconeo-
genic enzymes, glucose-6-phosphatase and fructose-1,6-
bisphosphatase, and fructose-2,6-bisphosphatase, an
enzyme unique to fructose metabolism and regulating fruc-
tose-1,6-bisphosphatase activity. Furthermore, not only
genes related to sugar metabolism and transport, but also
other genes changed their expression in response to high
fructose perfusion, for example, transcription factors. This
shows that many signalling and metabolic pathways in
the small intestine are responsive to the presence of one
single nutrient, i.e. in this case fructose, in the intestinal
lumen. In addition, it has been shown in rats that the intes-
tine is fructose insensitive before approximately age 14 d,
i.e. GLUT5 can be regulated by fructose when pups are
weaning but not when pups are suckling(150). Thus, the
ontogenic development of the intestine determines
when substrate regulation of GLUT5 can occur. GLUT5 is
a model of developing transporter systems in the small
intestine, as it has sharply defined stages that are character-
ised by differences in the ability of its substrate to regulate
GLUT5 transcription. Furthermore, it was shown that a pre-
mature induction of GLUT5 expression and fructose uptake
can be induced by glucocorticoids in suckling rats aged
10 d(151). Biologically, this could mean that, in case the
mother is under stress, it may release high levels of gluco-
corticoids with the milk(152) that subsequently and prema-
turely enable the small intestine of the young to digest and
absorb nutrients from the environment, thereby improving
its survival rate in the event of the loss of the mother. This
indicates developmental plasticity providing the ability of
the intestine to change function in response to environ-
mental cues(151). Although these studies have been per-
formed with rats, they provide valuable information for
dietary regulation of nutrient digestion and transport by
their respective substrates, but also that specific nutrients
are able to influence intestinal gene expression beyond
their own metabolism. Furthermore, with regard to
GLUT5 regulation, it becomes clear that several factors
may be involved in regulatory mechanisms, i.e. substrate
and age, but that there also exists the possibility to
modify regulatory mechanisms by external factors, for
example, by diet.
Fermentable carbohydrates
Digestive function and nutrient metabolism. Tako
et al.(153) assessed the effect of dietary inulin (4 %) on the
gene expression of selected intestinal Fe transport proteins
in anaemic piglets (aged 5 weeks, injected with only half of
the normal Fe dose, 50 mg Fe as Fe-dextran), using semi-
quantitative RT-PCR analyses (Table 4). In this study,
mRNA levels of intestinal Fe transporters, enzymes and
binding proteins in duodenal samples were significantly
higher in the inulin group compared with the control. In
the colon, expression of the pig divalent metal transporter
1, transferrin receptor and ferritin significantly increased
for the inulin group as well. Furthermore, a 100 % increase
in duodenal mucin mRNA level was observed for the inulin
group. For fermentable carbohydrates such as inulin, it can
be assumed that they may undergo microbial fermentation
in the large intestine leading to the production of
SCFA(19,97), although considerable amounts may already
be fermented before the distal ileum(154,155). Although
SCFA concentrations were not determined in the study of
Tako et al.(153), there were significant increases in caecal
populations of lactobacilli and bifidobacteria, suggesting
also a possible effect on SCFA concentrations. Thus,
according to the authors, one possible pathway by which
inulin might affect intestinal gene expression would be
via an increased SCFA production in the colon leading to
a possible systemic effect of butyrate on Fe metabolism.
Immune function. An example for the modification of
inflammatory conditions by dietary means is provided by
a study of Kanauchi et al.(156) in mice with induced colitis

















that were fed a diet containing germinated barley (defined
as a prebiotic product rich in hemicelluloses, which also
contains glutamine-rich protein). This dietary treatment
prevented disease activity after induction of colitis, associ-
ated with increased caecal butyrate concentration,
decreased serum IL-6 levels as well as a tendency for
reduced NF-kB expression. The authors suggest that the
anti-inflammatory effects of the germinated barley may
be due to increased butyrate production, possibly
mediated via inhibition of NF-kB.
In Table 4, studies pertaining to effects of dietary sup-
plementation with fermentable carbohydrates on intestinal
gene expression in pigs are summarised. For example, Pie´
et al.(74) investigated the effect of added fermentable
carbohydrates on the mRNA content of several pro-inflam-
matory cytokines (for example, IL-1b, IL-6, IL-8, IL-18,
TNF-a) in the ileum and colon of newly weaned piglets.
Fermentation endproducts were also assessed. The carbo-
hydrate-enriched diet induced an up-regulation of IL-6
mRNA content in the colon of piglets 4 d post-weaning,
which was not observed for the piglets fed the control
diet. This indicates that the regulation of IL-6 mRNA in
the colon depends on dietary factors, or at least on micro-
biological factors that have been influenced by the diet.
However, in this study, comparisons of IL-6 mRNA
contents with SCFA (acetic, propionic and butyric acids)
concentrations in the ileum and colon showed no corre-
lations, indicating that the increased level of this cytokine
was not directly dependent of the presence of SCFA. In
addition, an increase in IL-1b mRNA was observed at day
4 post-weaning in piglets fed the carbohydrate diet, and
also in the control group, suggesting that the level of this
cytokine is not influenced by diet composition. In another
study with piglets(27), a rapid increase in IL-1b after wean-
ing was obtained. Obviously, the observed responses are
more general, i.e. reflecting early immunological changes
associated with weaning, or other stress, in piglets. A
further study with piglets (aged 15 d) fed fermentable
carbohydrates showed enhanced IL-1b mRNA levels in
the jejunal mucosa and mesenteric lymph nodes, as well
as increased serum levels of IL-1b(157). Consistently,
serum levels of IL-2 and IL-6 in piglets fed the carbo-
hydrates were higher than in control animals. The authors
suggested that such an increase in inflammatory cytokines
may result from activation of some intestinal bacteria
which then stimulated an immune defence response(158).
Schedle et al.(159) used a piglet model to investigate the
immunological response of gastrointestinal tissues to diet-
ary additions of insoluble fibre, either wheat bran (rich in
cellulose and hemicelluloses) or pine pollen (rich in
lignin), measured as relative mRNA expression levels of
different transcription factors (NF-kB), inflammatory
marker genes (TNF-a, TGF-b), as well as markers of the
cell cycle (caspase 3, CDK4) and growth factors (Table 4).
According to this study, NF-kB, TNF-a, TGF-b and caspase
3 were up-regulated in the proximal part of the GIT due to
supplemental wheat bran, suggesting that the impact of
insoluble dietary fibre is not limited to the colon. Further-
more, due to a down-regulation of NF-kB in the colon
caused by pine pollen, the authors suggested a reduction
in pro-inflammatory action in colonic tissue. In this
study, Schedle et al.(159) also measured morphological par-
ameters, and found an increased villous height of the
mucosa in the jejunum and ileum due to insoluble dietary
fibre. In addition, TGF-b was up-regulated in the stomach
and jejunum by insoluble fibre, which is in line with a pro-
nounced cell proliferation and an increase in villus size.
They concluded that additions of insoluble fibre rich in
lignin might significantly contribute to GIT stability, in
terms of increased cell proliferation and reduced inflam-
mation in weaning piglets, however, not only with regard
to the colon, but rather to the entire digestive tract.
Table 4. Effect of dietary supplementation with fermentable carbohydrates on intestinal gene expression in piglets
Fermentable carbohydrate Intestinal segment Effect Reference
Nutrient absorption
Inulin (4 %) Duodenum Divalent metal transporter 1, duodenal
cytochrome-b reductase, ferroportin, ferritin,
transferrin receptor mRNA "
153
Colon Divalent metal transporter 1, transferrin receptor,
ferritin mRNA "
Immune function and growth factors
Lactulose, inulin, sugarbeet pulp,
wheat starch
Colon IL-6 mRNA " 74





IL-1b mRNA " 157
Serum IL-1b, IL-2, IL-6 "
Wheat bran Stomach, jejunum NF-kB mRNA " 159
Jejunum TNF-a, TGF-b, caspase 3 mRNA "
Chinese pine pollen Colon NF-kB, TNF-a, TGF-b, caspase 3, CDK4,
IGF-I mRNA #
Mesenterial lymph nodes NF-kB, TGF-b mRNA "
" , Increase; TGF, transforming growth factor; IGF, insulin-like growth factor; # , decrease.

















However, the insoluble fibre used in this study appeared to
be not fermentable. So, no relationships to bacterial metab-
olites were drawn and the primary mode of action remains
unclear.
Growth factors. Several studies in, for example, rats
and dogs(160,161) have shown that diets supplemented
with fermentable carbohydrates up-regulate the levels of
intestinal proglucagon mRNA, as well as the amount of
proglucagon-derived peptides (PGDP), when compared
with diets containing no or a low content of fermentable
carbohydrates (Table 5). The increase in intestinal proglu-
cagon expression is probably due to carbohydrate fermen-
tation in the colon and its simultaneous production of
SCFA(162–164). Indeed, SCFA are known to increase proglu-
cagon mRNA in the ileum of rats(165,166). With regard to the
various physiological effects of intestinal PGDP, for
example, intestinotrophic function, a stimulation of intesti-
nal PGDP synthesis and secretion by ingestion of specific
dietary components might be of interest during disease
or intestinal insufficiency. For GLP-1, but also for GLP-2,
it seems that there is the possibility to modulate its
endogenous availability via an enhanced production of
the precursor proglucagon mRNA through the ingestion
of fermentable carbohydrates(167–170).
Bacterial community and metabolites
Microbiota–host interactions. Extensive cross-talk
between the microbiota and the intestinal epithelium
takes place, and the intestinal microbiota influences the
GIT and the host as such(171). Thus, modulation of the bac-
terial community by dietary ingredients, such as carbo-
hydrate sources(172), can have sustainable effects on
intestinal development and integrity. For instance, activities
of brush-border enzymes, such as disaccharide hydrolases,
peptidases and alkaline phosphatase, which are markers of
enterocyte differentiation, are modified by intestinal
bacterial colonisation(173,174). In gnotobiotic animals, i.e.
germ-free animals colonised with one or a few bacterial
species, the effects of individual bacterial strains or defined
groups of strains on the host epithelium can be investi-
gated. For instance, Hooper et al.(175) used a gnotobiotic
mouse model to examine gene expression responses
following monoassociation with Bacteroides thetaiotaomi-
cron. Using DNA microarrays, laser-capture microdissec-
tion and quantitative RT-PCR, Hooper et al.(175)
determined that B. thetaiotaomicron modulated the
expression of seventy-one intestinal genes involved in
nutrient absorption, mucosal barrier fortification, xeno-
biotic metabolism, angiogenesis and postnatal intestinal
maturation. Colonisation of conventional mice with Lacto-
bacillus paracasei spp. paracasei F19 or L. acidophilus
NCFB 1748 induced significant regulation of twenty-two
and fifty-five genes involved in essential physiological
functions such as the immune response, regulation of
energy homeostasis and host defence in the distal ileum,
respectively, whereas only twenty genes were regulated
by both strains(176). Using a neonatal pig model, Siggers
et al.(174) showed that monoassociation of pigs with
L. fermentum stimulated the prohormone proglucagon
expression, whereas monoassociation with E. coli
decreased it. Many cleaved peptides from proglucagon
have important biological activities, such as GLP-2 that is
involved in epithelial proliferation, decreased epithelial
apoptosis and increased nutrient absorption(177). Moreover,
Willing & Van Kessel(178) demonstrated that association of
neonate piglets with conventional bacteria or monoasso-
ciation with E. coli but not with L. fermentum increased
overall cell turnover in the small intestine by stimulating
increased apoptosis through the expression of death
ligand Fas ligand and TNF-a and by increasing cell prolifer-
ation. Throughout the GIT the most significant molecular
function affected by the microbiota is the activity of pro-
teins involved in defence or immune responses(171), and
all genes with this annotation are up-regulated in the
small and large intestines of conventional mice and piglets
compared with germ-free animals(179,180). When germ-free
piglets were conventionalised, epithelial inflammatory
Table 5. Effect of fermentable carbohydrates on intestinal proglucagon gene expression and proglucagon-derived peptide production
Fermentable carbohydrate Species and intestinal segment Effect Reference
30 % fibre diet, 14 d (pea, oat, sugarbeet,
xanthan gum) (v. fibre-free diet)
Rat, ileum Proglucagon mRNA " 162
Circulating GLP-1 and insulin "
(after glucose challenge)
Rhubarb fibre diet (50 g/kg), 14 d (v. cellulose) Rat, ileum Proglucagon mRNA " 222
High-fermentable fibre diet (sugarbeet pulp,
gum arabic, fructo-oligosaccharide), 14 d
(v. cellulose)
Dog, ileum Proglucagon mRNA " 160
GLP-1 "
30 % fibre diet, 14 d (v. fibre-free diet) Wild-type and transgenic mice,
colon, jejunum and ileum
Endogenous murine proglucagon mRNA " 94
Oligofructose-enriched diet (10 %), 3 weeks
(v. standard diet)
Rat, proximal colon Proglucagon mRNA " 161
GLP-1 "
Oligofructose-enriched (10 %) high-fat diet Rat, caecum and colon Proglucagon mRNA " 169
Proximal colon GLP-1 " , GLP-2 "
" , Increase; GLP, glucagon-like peptide.

















responses were detected in the ileum using high-density
porcine oligonucleotide microarrays. Genes involved in
epithelial cell turnover, mucus biosynthesis and priming
of the immune system were induced. Receptors and tran-
scription factors related to IFN-inducible genes were up-
regulated; however, at the same time, the inflammatory
response seemed to be controlled through activation of
genes in pathways that prevent excessive inflammation,
supporting the concept of a homeostatic epithelium that
maintains a tight intestinal barrier without producing
excessive inflammatory responses, which would compro-
mise barrier function(181). Overall, the microbiota affects a
multitude of epithelial functions in the intestine as a conse-
quence of specific bacterial–host interactions, and these
extend far beyond the immune response (for a review,
see Leser & Mølbak(171)).
SCFA. The ability of SCFA, particularly butyrate, to
influence gene expression is increasingly considered.
One well-known mechanism of butyrate to influence
gene expression is via the induction of histone hyperacety-
lation through the inhibition of histone deacetylase
(HDAC). By this means, the compactness of the histone
is reduced, and the DNA is more accessible to transcription
factors(182,183). Among the different SCFA with different
chain lengths, butyrate is most effective in inhibiting
HDAC activity(182,184). In Table 6, in vitro studies using cul-
tured intestinal cells to investigate the influence of butyrate
on cytokine gene expression are summarised. This might
be of special importance with regard to inflammatory dis-
eases, as particularly butyrate has been shown to suppress
intestinal inflammation (for example, Harig et al.(185)). For
example, colonic secretion of IL-8, a chemotactic and acti-
vating peptide for neutrophils(186,187), is increased in
human ulcerative colitis ex vivo, but is suppressed by buty-
rate(188). A possible molecular mechanism to mediate the
effects of butyrate is via modification of transcription
factor activation. Segain et al.(189) showed in LPS-stimulated
lamina propria mononuclear cells, and in the colonic
mucosa of mice with induced colitis that butyrate
prevented the nuclear translocation of NF-kB. The inhibi-
tory effect of butyrate on NF-kB activation was also
confirmed by Zapolska-Downar et al.(190) in endothelial
cells. It seems that the anti-inflammatory effects of butyrate
– at least in part – are mediated via inhibition of NF-kB(189)
which regulates the expression of genes involved in the
inflammatory response, for example, cytokines such as
TNF(191). It has been proposed that the inhibitory effect
of butyrate on NF-kB activation originates from its ability
to inhibit HDAC activity(192). On the other hand, Weber &
Kerr(193) could not find in vivo effects of dietary sodium
butyrate on the ileal relative abundance of cytokine
mRNA (IL-6, TNF-a) in weanling pigs challenged with
E. coli LPS. This is in contrast to Milo et al.(194) who
found in young pigs that parenterally fed SCFA increased
intestinal IL-6 abundance. Weber & Kerr(193) hypothesised
that due to the anti-inflammatory activity of butyrate(195)
and other HDAC inhibitors(196), butyrate might decrease
the cytokine response to LPS. The lack of response in the
study of Weber & Kerr(193) could be due to the different
routes of administration for butyrate, or could be due to
the fact that Milo et al.(194) used a combination of SCFA.
With regard to effects on growth factors, it has been
shown in vitro that butyrate, and to a lesser extent other
SCFA, increased the synthesis of IGFBP-2 by the intestinal
epithelial cell line Caco-2 (via histone acetylation). Simul-
taneously, synthesis of IGFBP-3, which is predominantly
secreted in the absence of SCFA, is decreased(197). Changes
in IGFBP secretion corresponded to mRNA accumulation.
Altering the profile of IGFBP may have profound effects
on the bioavailability of IGF-I and IGF-II. Obviously, epi-
thelial cells respond to bacterial products, i.e. SCFA, by
secreting proteins that may modulate factors that affect
their own proliferation and that of other intestinal cell
types(197). With regard to the proliferative effects of the
IGF system, for example, on intestinal epithelial cells, it
has been suggested that changes in the expression of
IGF-I, IGF-IR and IGFBP in the intestine may play an
important role in limiting mucosal damage or promoting
tissue repair. This might be of importance for the adaptive
function of the small intestine in response to weaning and
during inflammation(89,198).
Polyamines. Expression of enzymes and transporters
related to digestion and absorption may also be influenced
by polyamines(199), originating from microbial proteolysis(97),
Table 6. Influence of butyrate on cytokine gene expression of cultured intestinal cells
Cells used Treatment Effect Reference
HIMEC Sodium butyrate, stimulation with LPS IL-6 mRNA, IL-6 # 223
IL-8 mRNA –
Intestinal epithelial cells (Caco-2) Sodium butyrate, stimulation with IL-1b or LPS IL-8 mRNA, IL-8 " 224
Intestinal epithelial cells (Caco-2) Butyrate, resting cells or stimulation with IL-1b IL-8 mRNA, IL-8 " 184
MCP-1 mRNA, MCP-1 #
Intestinal biopsy specimens and isolated
lamina propria mononuclear cells from
Crohn’s disease patients
Butyrate TNF-b mRNA, TNF, IL-6 mRNA,
IL-6, IL-1b mRNA, IL-1b #
189
Peripheral blood mononuclear cells Butyrate, stimulation with LPS TNF-a mRNA, TNF-b mRNA, TNF,
IL-6 mRNA, IL-1b mRNA #
HIMEC, human intestinal microvascular endothelial cells; LPS, lipopolysaccharide; # , decrease; –, no effect; " , increase; MCP-1, monocyte chemoattractant protein-1.

















or from dietary sources(200), for example, from mother’s
milk(201). In a study of Wild et al.(199), it has been shown
that oral polyamine administration may modify the
ontogeny of hexose transporter gene expression in the
postnatal rat intestine. In this study, the polyamine spermi-
dine, supplied at a level similar to the concentration
in rat breast milk(202), increased the abundance of mRNA
for sucrase–isomaltase, SGLT1 and GLUT2, as well as
ornithine decarboxylase (ODC) activity and protein and
mRNA abundance. The maturational changes in enzyme
expression have been correlated to both mucosal polya-
mine levels and to the onset of the expression and activity
of ODC, the key enzyme of polyamine biosynthesis(203).
The study of Wild et al.(199) suggests that normal ontogenic
expression of the digestion and absorption of glucose may
be modified by an exogenous polyamine (spermidine),
acting through the increase in ODC activity, which, in
turn, enhances the mRNA and protein abundance of the
enzymes and transporters involved in this process.
Furthermore, polyamines originating from microbial pro-
teolysis may be involved in the expression of genes related
to the innate immune system. Chen et al.(204) showed
in vitro, by use of a cell line from the normal rat small
intestine (IEC-6 cell line), that polyamines are necessary
for Toll-like receptor (TLR)2 expression. Intestinal
epithelial cells (IEC) express a variety of potential
sensing receptors, including TLR, which are fundamental
components of the innate immune response and allow
mammalian intestinal epithelium to detect various
microbes and different pathogens(205,206). Thus, the polya-
mine-modulated TLR2 activation plays an important role in
the regulation of the epithelial barrier function. It seems
that polyamines are crucial for the maintenance of the
epithelial barrier integrity and mucosal homeostasis
under physiological conditions(204).
Limitations and strengths of gene expression to determine
implications of nutrition during weaning
Research has focused on mechanisms controlling gene
expression, and the impact of biological and external fac-
tors on gene expression. Before the genomic approach
was introduced in science, molecular biology aimed at
investigating single genes or proteins, and their structure
and function, in isolation from the larger context of other
genes. The limitation of this approach is the need for a
working hypothesis. Furthermore, it appears that physio-
logical processes are governed by several genes acting in
concert rather than by only one or a few individual
genes. Genomic technologies such as array technology
and large-scale DNA sequencing techniques facilitated
the analysis of thousands of genes or proteins or
metabolites in a single experiment (genomic approach).
This approach is generating hypotheses and allows
the identification of novel relevant genes to be further
studied(207).
However, it is of major importance to identify interde-
pendences between different classes of measurements
(for example, zootechnical data v. histological v. gene
expression data)(159), and to obtain more additional infor-
mation on possible modes of action by methods of bioin-
formatics (cluster analysis, comparison of thousands of
expressed mRNA)(208). For example, Hamard et al.(209)
investigated both the physiological disturbances and mol-
ecular events caused by an inadequate threonine supply
to the ileum of piglets. Gene expression profiles were com-
pared with responses of physiological origin. Most of the
changes were consistent with an increase in metabolic
activity including, for example, protein synthesis. The
authors concluded that comparison of transcriptomic and
physiological data may allow a better understanding of
the functional implication of these genes as well as associ-
ated mechanism of regulation. However, to validate links
between changes of gene expression and function, it is
necessary to confirm biological interpretation of these
results. Furthermore, it has to be kept in mind that data
from gene expression studies may sometimes appear
relatively unclear, because they are reflecting reactions of
homogenised tissue segments, comprising different cell
types. Thus, it would be necessary to link mRNA measure-
ments with specific individual cell types (for example,
by means of micro-dissection or immune histological
techniques)(159).
In consequence, although a direct correlation between
transcriptomic regulation and functional impact is not
always easy to establish, studies exist suggesting fasting/
refeeding-induced gene regulations (for example, Mazurais
et al.(35)) to be consistent with alterations in the small intes-
tine in piglets at weaning (for example, Marion et al.(210);
Boudry et al.(24)). Thus, although given the limitation of
gene expression studies, for example, need for compari-
sons between changes in gene expression with other, for
example, morphological or zootechnical parameters, use
of gene expression studies will help to gain deeper insight
into the mechanism governing the physiological functions
and their regulation in livestock species(207). In that way, it
will become possible to evaluate feeding regimens, com-
pounds for non-pharmaceutical prevention of infectious
enteral disease, and evaluation of pharmaceutical treat-
ment of enteral diseases(36).
Implications for pig nutrition
Dietary invention to prevent disease through feed sup-
plementation has become a standard procedure in
modern pig production systems. This requires, however,
understanding of the ability to manipulate a multitude of
nutrient-related interactions at the gene, protein and
metabolic levels. Comparison of transcriptomic and
physiological data may allow a better understanding of
the functional implication of these genes as well as
associated mechanisms of regulation(209). Although direct

















correlation between transcriptomic regulation and func-
tional impact is not always easy to establish, numerous
studies have shown that nutrition-induced gene regulations
observed are consistent with changes in intestinal structure
and function.
By use of microarray technology, it has been shown that
early weaning may lead to an increased expression of
genes that promote oxidative stress and immune activation
but decreased expression of genes related to nutrient util-
isation and cell proliferation in the piglet’s small intes-
tine(7). However, as weaning generally is associated with
a reduced feed intake(21), a clear distinction between
effects of weaning and associated reduced feed intake on
gene expression seems to be impossible. Also, weaning
at early maturation stages frequently causes mucosal
inflammation, which can be seen from an enhanced
expression of pro-inflammatory cytokines. Thus, nutri-
tional strategies are in favour that are capable of manipulat-
ing the secretion of pro-inflammatory cytokines(144).
Specific dietary fatty acids (for example, CLA) may have
therapeutic potential, since they are able to influence the
inflammatory response via specific transcription fac-
tors(139). Furthermore, specific feed ingredients, such as lin-
seed, have been suggested as potential functional
ingredients which may affect intestinal gene expression
in young piglets after weaning(211). Linseed contains a
number of constituents, such as mucilage, gel-forming
polysaccharides, structural carbohydrates and n-3 fatty
acids, which could have functional properties in relation
to maintaining and supporting gastrointestinal health in
post-weaning piglets. For example, mRNA abundance of
a lectin with anti-inflammatory properties which is
expressed in the intestinal epithelium and involved in
innate defence mechanisms was higher in linseed-fed
pigs than in pigs fed the control diet. Stimulation or inhi-
bition of such genes by feeding piglets a diet with specific
functional constituents may be a promising way to improve
intestinal health under stressful conditions such as
weaning.
Also, providing a diet that best accommodates the profile
of digestive enzymes and nutrient transporters present in
the gut will result in improved utilisation of dietary nutri-
ents, improved health and growth. For example, from a
commercial livestock industry perspective, dietary protein
is a costly nutrient, and even fractional improvements in
its utilisation have the potential to reduce production
costs as well as reduce the N excretion into the environ-
ment. Although dietary protein regulation of peptide trans-
porter expression and activity has not been intensively
studied in livestock, much of the work conducted in
species used in biomedical research is broadly applicable,
and provides a starting point for other studies aimed at
determining the nutritional relevance of peptide trans-
port(39). Further approaches may be based on the stimu-
lation and promotion of rapid gastrointestinal
development, thus supporting the animal to better cope
with dietary changes associated with weaning. In this con-
text, brush-border enzymes, such as lactase or maltase,
are frequently used as cell markers of villus matu-
ration(212–214). Accordingly, supplementation with specific
dietary ingredients might offer the possibility to enhance
proliferation and differentiation of epithelial cells and
stimulate enzyme production in the upper GIT of
weaned piglets.
Effects of specific dietary components may also be
mediated rather indirectly via the metabolites produced
from these components by the gastrointestinal microbiota,
such as SCFA from carbohydrate fermentation or polya-
mines, which originate from protein fermentation. By
changing the source and quantity of components available
as fermentable substrates in the distal parts of the GIT, it
may be possible to alter the amount and composition of
microbial metabolites. For the SCFA, and particularly buty-
rate, it has been shown that they can influence the
expression of various genes in the intestine, including, for
example, cytokine expression. According to Pie´ et al.(74),
a diet enriched in fermentable carbohydrates can modulate
the IL-6 mRNA content during the weaning period in pig-
lets. Correlations between several pro-inflammatory cyto-
kines and the endproducts of fermentation demonstrated
that the regulation of cytokines is strongly linked to
fermentation endproducts. As cytokines play a major role
in the maintenance of gastrointestinal homeostasis, their
regulation by nutritional factors may be an important con-
sideration in the future for the development of new diet
formulas for newly weaned piglets. Furthermore, dietary
regulation of intestinal proglucagon expression via the
ingestion of fermentable carbohydrates, associated with
an increase in SCFA production, seems to be a promising
approach in view of the physiological effects of intestinal
PGDP. GLP-2, which may act as a physiological regulator
of intestinal growth, has been suggested as a treatment
for gastrointestinal diseases characterised by intestinal dys-
function. A stimulation of endogenous intestinal PGDP
synthesis by the ingestion of specific dietary components
could represent an alternative approach to exogenous
GLP administration, and might be of considerable interest
for therapeutic approaches.
However, it has to be kept in mind that changes in the
intestine as they occur at weaning are often more a conse-
quence of reduced feed intake, stress and inflammation
than of dietary changes. This has been shown when inves-
tigating the impact of switching from milk-based to cereal-
based diets on the morphology and function of the small
intestine in piglets to isolate the influence of the diet
from that of other factors, such as social or environmen-
tal(215). With regard to mucosal integrity, the effect of diet
composition seems not to be as important as the sequential
effects of low feed intake during the first 4 d post-weaning.
Accordingly, alterations of intestinal integrity were also
observed in underfed piglets and piglets receiving TPN,
when compared with their counterparts ad libitum or

















receiving enteral nutrition, independently of the weaning
process(26,56). Thus, based on the present review, one
major consequence would be stimulation of feed intake
of piglets in the early post-weaning phase through various
measures. This includes the use of specific feed ingredients
that are well accepted by the animals. For example, dairy
products, such as whey or skimmed milk powder have
favourable effects on feed intake, and thus on health and
growth performance(216). Or, providing a weaner diet in
liquid form enhances feed intake and thus health(217).
Also, supplementation of weaner diets with animal protein,
for example, spray-dried plasma, may increase growth per-
formance, most likely due to an increased feed intake,
probably due to its high palatability, but also due to the
anabolic activity of IGF-I present in spray-dried
plasma(218).
As nutrient composition and availability seem to be more
important in the reparative phase(219), understanding how
dietary factors can alter intestinal gene expression is an
early step in the realisation of their therapeutic poten-
tial(220). The development of new strategies might involve
stimulation of the immune response, reduction of the
inflammatory response and improvement of nutrient diges-
tion and transport. Improvement of the gut barrier function
and mucosal repair by dietary factors might be other strat-
egies to further improve health and animal performance.
This can support intestinal health in times of disease or
compromised feed intake such as at weaning. For such
purposes, molecular nutritional science is of central inter-
est. The response of mammalian organisms to changes in
their nutritional environment may be detected at the
mRNA and/or protein levels by different means, including
expression arrays and proteome analysis, but also by use of
transgenic approaches(221). Such tools will allow identify-
ing the mechanisms and pathways involved in the complex
relationship between host factors and nutrition, but also
the intestinal microflora.
Conclusions
In conclusion, dietary factors may have major impacts on
intestinal gene expression, and deeper understanding of
the underlying mechanisms and pathways is an early step
in the realisation of their therapeutic potential. Stimulation
or inhibition of genes by using specific functional constitu-
ents may be a convenient way to improve intestinal health
under stressful conditions. For example, improvement of
the gut barrier function and mucosal repair by dietary fac-
tors might be an interesting strategy to improve health and
animal performance. In that way, intestinal health may be
supported in times of disease or compromised feed
intake such as at weaning. Furthermore, nutrients may be
used by the intestinal microbiota resulting in the pro-
duction of bacterial metabolites, which also may affect
intestinal gene expression. Thus, modulation of the
bacterial community by dietary ingredients, such as
carbohydrate sources, can have sustainable effects on, for
example, intestinal development and integrity. Since the
microbiota affects a multitude of epithelial functions in
the intestine due to specific bacterial–host interactions,
the complex relationship between host, nutrition and intes-
tinal microbiota has to be kept in mind when evaluating
nutrition as a tool to influence gene expression.
Acknowledgements
This research received no specific grant from any funding
agency in the public, commercial or not-for-profit sectors.
R. M., M. W. A. V. and E. B. were responsible for the con-
ceptualisation and implementation of the manuscript. E. B.
and B. U. M.-Z. wrote the manuscript. All authors reviewed
the manuscript and approved it before submission. The
authors wish to thank Ingrid Neff for assisting in preparing
the manuscript.
There are no conflicts of interest.
References
1. Lalle`s JP, Boudry G, Favier C, et al. (2004) Gut function and
dysfunction in young pigs: physiology. Anim Res 53,
301–316.
2. McCracken BA, Spurlock ME, Roos MA, et al. (1999) Wean-
ing anorexia may contribute to local inflammation in the
piglet small intestine. J Nutr 129, 613–619.
3. Ihara T, Tsujikawa T, Fujiyama Y, et al. (2000) Regulation of
PepT1 peptide transporter expression in the rat small intes-
tine under malnourished conditions. Digestion 61, 59–67.
4. Ihara T, Tsujikawa T, Fujiyama Y, et al. (2000) Enhancement
of brush border membrane peptidase activity in rat jejunum
induced by starvation. Pflugers Arch 440, 75–83.
5. Ziegler TR, Almahfouz A, Pedrini MT, et al. (1995) A com-
parison of rat small intestinal insulin and insulin-like
growth factor I receptors during fasting and refeeding.
Endocrinology 136, 5148–5154.
6. Hoyt EC, Lund PK, Winesett DE, et al. (1996) Effects of fast-
ing, refeeding, and intraluminal triglyceride on proglucagon
expression in jejunum and ileum. Diabetes 45, 434–439.
7. Wang J, Chen L, Li P, et al. (2008) Gene expression is altered
in piglet small intestine by weaning and dietary glutamine
supplementation. J Nutr 138, 1025–1032.
8. Dauncey MJ, White P, Burton KA, et al. (2001) Nutrition–
hormone receptor–gene interactions: implications for
development and disease. Proc Nutr Soc 60, 63–72.
9. Mu¨ller M & Kersten S (2003) Nutrigenomics: goals and strat-
egies. Nat Rev Genet 4, 315–322.
10. Mangelsdorf DJ, Thummel C, Beato M, et al. (1995) The
nuclear receptor superfamily: the second decade. Cell 83,
835–839.
11. Schoonjans K, Staels B & Auwerx J (1996) Role of the per-
oxisome proliferator-activated receptor (PPAR) in mediating
the effects of fibrates and fatty acids on gene expression.
J Lipid Res 37, 907–925.
12. Kersten S, Desvergne B & Wahli W (2000) Roles of PPARs in
health and disease. Nature 405, 421–424.
13. Jiang C, Ting AT & Seed B (1998) PPAR-g agonists inhibit
production of monocyte inflammatory cytokines. Nature
391, 82–86.

















14. Marx N, Sukhova GK, Collins T, et al. (1999) PPARa activa-
tors inhibit cytokine-induced vascular cell adhesion mol-
ecule-1 expression in human endothelial cells. Circulation
99, 3125–3131.
15. Pluske JR, Hampson DJ & Williams IH (1997) Factors
influencing the structure and function of the small intestine
in the weaned pig: a review. Livest Prod Sci 51, 215–236.
16. Savage DC (1977) Microbial ecology of the gastrointestinal
tract. Ann Rev Microbiol 31, 107–133.
17. Cousins RJ (1999) Nutritional regulation of gene expression.
Am J Med 106, Suppl. 1, 20S–23S.
18. Davie JR (2003) Inhibition of histone deacetylase activity by
butyrate. J Nutr 133, 2485S–2493S.
19. Williams BA, Verstegen MWA & Tamminga S (2001) Fermen-
tation in the large intestine of single-stomached animals and
its relationship to animal health. Nutr Res Rev 14, 207–227.
20. Williams BA, Bosch MW, Boer H, et al. (2005) An in vitro
batch culture method to assess potential fermentability
of feed ingredients for monogastric diets. Anim Feed Sci
Technol 123–124, 445–462.
21. Bruininx EMAM, Binnendijk GP, van der Peet-Schwering
CMC, et al. (2002) Effect of creep feed consumption on
individual feed intake characteristics and performance of
group-housed weanling pigs. J Anim Sci 80, 1413–1418.
22. Hampson DJ (1994) Postweaning Escherichia coli diarrhoea
in pigs. In Escherichia coli in Domestic Animals and
Humans, 2nd ed., pp. 171–191 [CL Gyles, editor]. Walling-
ford: CAB International.
23. Spreeuwenberg MAM (2002) Diet composition and
gut integrity in weaned piglets. PhD Thesis, Wageningen
University.
24. Boudry G, Peron V, Le Hue¨rou-Luron I, et al. (2004) Wean-
ing induces both transient and long-lasting modifications of
absorptive, secretory, and barrier properties of piglet intes-
tine. J Nutr 134, 2256–2262.
25. Goldstein RM, Hebiguchi T, Luk GD, et al. (1985) The
effects of total parenteral nutrition on gastrointestinal
growth and development. J Pediatr Surg 20, 785–791.
26. Carey HV, Hayden UL & Tucker KE (1994) Fasting alters
basal and stimulated ion transport in piglet jejunum. Am J
Physiol Regul Integr Comp Physiol 267, R156–R163.
27. Pie´ S, Lalle`s JP, Blazy F, et al. (2004) Weaning is associated
with an upregulation of expression of inflammatory cyto-
kines in the intestine of piglets. J Nutr 134, 641–647.
28. McKay DM & Baird AW (1999) Cytokine regulation of epi-
thelial permeability and ion transport. Gut 44, 283–289.
29. Hillman K (2001) Bacteriological aspects of the use of anti-
biotics and their alternatives in the feed of non-ruminant
animals. In Recent Advances in Animal Nutrition,
pp. 107–134 [PC Garnsworthy and J Wiseman, editors].
Nottingham: Nottingham University Press.
30. Ewing WN & Cole DJA (editors) (1994) The Living Gut.
Dungannon: Context Publications.
31. Franklin MA, Mathew AG, Vickers JR, et al. (2002) Charac-
terization of microbial populations and volatile fatty acid
concentrations in the jejunum, ileum, and cecum of pigs
weaned at 17 vs 24 days of age. J Anim Sci 80, 2904–2910.
32. Janczyk P, Pieper R, Smidt H, et al. (2007) Changes in the
diversity of pig ileal lactobacilli around weaning deter-
mined by means of 16S rRNA gene amplification and dena-
turing gradient gel electrophoresis. FEMS Microbiol Ecol 61,
132–140.
33. Konstantinov SR, Awati AA, Williams BA, et al. (2006) Post-
natal development of the porcine microbiota composition
and activities. Environ Microbiol 8, 1191–1199.
34. Hooper LV & Gordon JI (2001) Commensal host–bacterial
relationships in the gut. Science 292, 1115–1118.
35. Mazurais D, Rome´ V, Cahu A, et al. (2007) Fasting and
refeeding impacts on piglet jejunal transcriptome during
weaning period. Livest Sci 108, 13–16.
36. Niewold TA, Kerstens HHD, Van der Meulen J, et al. (2005)
Development of a porcine small intestinal cDNA micro-
array: characterization and functional analysis of the
response to enterotoxigenic E. coli. Vet Immunol Immuno-
pathol 105, 317–329.
37. Castello A, Guma A, Sevilla L, et al. (1995) Regulation of
GLUT5 gene expression in rat intestinal mucosa: regional
distribution, circadian rhythm, perinatal development and
effect of diabetes. Biochem J 309, 271–277.
38. Adibi SA (1997) The oligopeptide transporter (Pept-1) in
human intestine: biology and function. Gastroenterology
113, 332–340.
39. Gilbert ER, Wong EA & Webb KE Jr (2008) Board-invited
review: Peptide absorption and utilization: implications
for animal nutrition and health. J Anim Sci 86, 2135–2155.
40. Ogihara H, Suzuki T, Nagamachi Y, et al. (1999) Peptide
transporter in the rat small intestine: ultrastructural localiz-
ation and the effect of starvation and administration of
amino acids. Histochem J 31, 169–174.
41. Thamotharan M, Bawani SZ, Zhou X, et al. (1999)
Functional and molecular expression of intestinal
oligopeptide transporter (Pept-1) after a brief fast.
Metabolism 48, 681–684.
42. Howard A, Goodlad RA, Walters JRF, et al. (2004) Increased
expression of specific intestinal amino acid and peptide
transporter mRNA in rats fed by TPN is reversed by
GLP-2. J Nutr 134, 2957–2964.
43. Adibi SA (2003) Regulation of expression of the intestinal
oligopeptide transporter (Pept-1) in health and disease.
Am J Physiol Gastrointest Liver Physiol 285, G779–G788.
44. Barbot L, Windsor E, Rome S, et al. (2003) Intestinal peptide
transporter PepT1 is over-expressed during acute cryptos-
poridiosis in suckling rats as a result of both malnutrition
and experimental parasite infection. Parasitol Res 89,
364–370.
45. Shimakura J, Terada T, Saito H, et al. (2006) Induction
of intestinal peptide transporter 1 expression during
fasting is mediated via peroxisome proliferator-activated
receptor a. Am J Physiol Gastrointest Liver Physiol 291,
G851–G856.
46. Francis GA, Fayard E, Picard F, et al. (2003) Nuclear recep-
tors and the control of metabolism. Annu Rev Physiol 65,
261–311.
47. Corthe´sy-Theulaz I, Den Dunnen JT, Ferre P, et al. (2005)
Nutrigenomics: the impact of biomics technology on nutri-
tion research. Ann Nutr Metab 49, 355–365.
48. Dreyer C, Krey G, Keller H, et al. (1992) Control of the per-
oxisomal b-oxidation pathway by a novel family of nuclear
hormone receptors. Cell 68, 879–887.
49. Tontonoz P, Hu E & Spiegelman BM (1994) Stimulation of
adipogenesis in fibroblasts by PPARg2, a lipid-activated
transcription factor. Cell 79, 1147–1156.
50. Kersten S, Seydoux J, Peters JM, et al. (1999) Peroxisome
proliferator-activated receptor a mediates the adaptive
response to fasting. J Clin Invest 103, 1489–1498.
51. Kaminsky LS & Zhang QY (2003) The small intestine as a
xenobiotic-metabolizing organ. Drug Metab Dispos 31,
1520–1525.
52. Van den Bosch HM, Bu¨nger M, de Groot PJ, et al. (2007)
Gene expression of transporters and phase I/II metabolic
enzymes in murine small intestine during fasting. BMC
Genomics 8, 267.
53. Le Hue¨rou-Luron I, Petersen YM, Hartmann B, et al. (2003)
Exogenous GLP-2 has only marginal effects on weaning-

















induced intestinal adaptation in piglets. In Proceedings of
the 9th International Symposium on Digestive Phyisology
in Pigs, vol. 2, pp. 164–166 [RO Ball, editor]. Edmonton,
AB: University of Alberta.
54. Marion J, Petersen YM, Rome´ V, et al. (2005) Early weaning
stimulates intestinal brush border enzyme activities in pig-
lets, mainly at the posttranscriptional level. J Pediatr Gastro-
enterol Nutr 41, 401–410.
55. Montagne L, Boudry G, Favier C, et al. (2007) Main intesti-
nal markers associated with the changes in gut architecture
and gut function in piglets after weaning. Br J Nutr 97,
45–57.
56. Park YK, Monaco MM & Donovan SM (1998) Delivery of
total parenteral nutrition (TPN) via umbilical catheteriza-
tion: development of a piglet model to investigate therapies
to improve gastrointestinal structure and enzyme activity
during TPN. Biol Neonate 73, 295–305.
57. Matsunaga T, Shintani S & Hara A (2006) Multiplicity of
mammalian reductases for xenobiotic carbonyl com-
pounds. Drug Metab Pharmacokinet 21, 1–18.
58. Wildhaber BE, Yang H, Spencer AU, et al. (2005) Lack of
enteral nutrition-effects on the intestinal immune system.
J Surg Res 123, 8–16.
59. Kiristioglu I & Teitelbaum DH (1998) Alteration of the intes-
tinal intraepithelial lymphocytes during total parenteral
nutrition. J Surg Res 79, 91–96.
60. Yang H, Kiristioglu I, Fan Y, et al. (2002) Interferon-g
expression by intraepithelial lymphocytes results in a loss
of epithelial barrier function in a mouse model of total
parenteral nutrition. Ann Surg 236, 226–234.
61. Alverdy JC, Aoys E & Moss GS (1988) Total parenteral nutri-
tion promotes bacterial translocation from the gut. Surgery
104, 185–190.
62. Fukatsu K, Kudsk KA, Zarzaur BL, et al. (2001) TPN
decreases IL-4 and IL-10 mRNA expression in lipopolysac-
charide stimulated intestinal lamina propria cells but gluta-
mine supplementation preserves the expression. Shock 15,
318–322.
63. Kramer DR, Sutherland RM, Bao S, et al. (1995) Cytokine
mediated effects in mucosal immunity. Immunol Cell Biol
73, 389–396.
64. Abbas AK & Lichtman AH (editors) (2001) Basic
Immunology: Functions and Disorders of the Immune
System. Philadelphia, PA: W.B. Saunders Company.
65. Chipman DM & Sharon N (1969) Mechanism of lysozyme
action. Science 165, 454–465.
66. Wu G, Fang YZ, Yang S, et al. (2004) Glutathione
metabolism and its implications for health. J Nutr 134,
489–492.
67. Aw TT (1999) Molecular and cellular responses to oxidative
stress and changes in oxidation–reduction imbalance in the
intestine. Am J Clin Nutr 70, 557–565.
68. Young D, Fan MZ & Mine Y (2010) Egg yolk peptides up-
regulate glutathione synthesis and antioxidant enzyme
activities in a porcine model of intestinal oxidative stress.
J Agric Food Chem 58, 7624–7633.
69. Papparella A, DeLuca FG, Oyer CE, et al. (1997) Ischemia–
reperfusion injury in the intestines of newborn pigs. Pediatr
Res 42, 180–188.
70. Haase E, Bigam DL, Nakonechny QB, et al. (2004) Resusci-
tation with 100 % oxygen causes intestinal glutathione oxi-
dation and reoxygenation injury in asphyxiated newborn
piglets. Ann Surg 240, 364–373.
71. Mengheri E, Ciapponi L, Vignolini F, et al. (1996) Cytokine
gene expression in intestine of rat during the postnatal
developmental period: increased IL-1 expression at wean-
ing. Life Sci 59, 1227–1236.
72. Schaeffer C, Diab-Assef M, Plateroti M, et al. (2000) Cytokine
gene expression during postnatal small intestinal develop-
ment: regulation by glucocorticoids. Gut 47, 192–198.
73. Kandil HM, Berschneider HM & Argenzio RA (1994)
Tumour necrosis factor a changes porcine intestinal ion
transport through a paracrine mechanism involving prosta-
glandins. Gut 35, 934–940.
74. Pie´ S, Awati A, Vida S, et al. (2007) Effects of added fermen-
table carbohydrates in the diet on intestinal proinflamma-
tory cytokine-specific mRNA content in weaning piglets.
J Anim Sci 85, 673–683.
75. Ganessunker D, Gaskins HR, Zuckermann FA, et al. (1999)
Total parenteral nutrition alters molecular and cellular indi-
ces of intestinal inflammation in neonatal piglets. J Parenter
Enteral Nutr 23, 337–344.
76. Zijlstra RT, McCracken BA, Odle J, et al. (1999) Malnutrition
modifies pig small intestinal inflammatory responses to
rotavirus. J Nutr 129, 838–843.
77. Winesett DE, Ulshen MH, Hoyt EC, et al. (1995) Regulation
and localization of the insulin-like growth factor system in
small bowel during altered nutrient status. Am J Physiol
Gastrointest Liver Physiol 268, G631–G640.
78. Dahly EM, Guo Z & Ney DM (2002) Alterations in entero-
cyte proliferation and apoptosis accompany TPN-induced
mucosal hypoplasia and IGF-I-induced hyperplasia in rats.
J Nutr 132, 2010–2014.
79. Straus DS (1994) Nutritional regulation of hormones and
growth factors that control mammalian growth. FASEB J
8, 6–12.
80. Laburthe M, Rouyer-Fessard C & Gammeltoft S (1988)
Receptors for insulin-like growth factors I and II in rat gas-
trointestinal epithelium. Am J Physiol Gastrointest Liver
Physiol 254, G457–G462.
81. LeRoith D, Werner H, Beitner-Johnson D, et al. (1995)
Molecular and cellular aspects of the insulin-like growth
factor I receptor. Endocr Rev 16, 143–163.
82. Hardouin S, Hossenlopp P, Segovia B, et al. (1987) Hetero-
geneity of insulin-like growth factor binding proteins and
relationships between structure and affinity. 1. Circulating
forms in man. Eur J Biochem 170, 121–132.
83. Cohick WS & Clemmons DR (1993) The insulin-like growth
factors. Annu Rev Physiol 55, 131–153.
84. Simmen FA, Badinga L, Green ML, et al. (1998) The porcine
insulin-like growth factor system: at the interface of nutri-
tion, growth and reproduction. J Nutr 128, 315S–320S.
85. Rubin JS, Osada H, Finch PW, et al. (1989) Purification and
characterization of a newly identified growth factor specific
for epithelial cells. Proc Natl Acad Sci U S A 86, 802–806.
86. Housley RM, Morris CF, Boyle W, et al. (1994) Keratinocyte
growth factor induces proliferation of hepatocytes and epi-
thelial cells throughout the rat gastrointestinal tract. J Clin
Invest 94, 1764–1777.
87. Estı´variz CF, Gu LH, Scully S, et al. (2000) Regulation of ker-
atinocyte growth factor (KGF) and KGF receptor mRNAs by
nutrient intake and KGF administration in rat intestine. Dig
Dis Sci 45, 736–743.
88. Shoubridge CA, Steeb CB & Read LC (2001) IGFBP mRNA
expression in small intestine of rat during postnatal devel-
opment. Am J Physiol Gastrointest Liver Physiol 281,
G1378–G1384.
89. Tang M, Van Kessel AG & Laarveld B (2002) Effects of
weaning and rearing environment on intestinal gene
expression of IGF-I, IGFBP (1-6), and the IGF receptor
and on specific binding of IGF-I to mucosal membranes
in the pig. Gen Comp Endocrinol 128, 205–213.
90. Brubaker PL & Drucker DJ (2004) Minireview: Glucagon-
like peptides regulate cell proliferation and apoptosis

















in the pancreas, gut, and central nervous system.
Endocrinology 145, 2653–2659.
91. Holst JJ (1997) Enteroglucagon. Annu Rev Physiol 59,
257–271.
92. Shin ED, Estall JL, Izzo A, et al. (2005) Mucosal adaptation
to enteral nutrients is dependent on the physiologic actions
of glucagon-like peptide-2 in mice. Gastroenterology 128,
1340–1353.
93. Burrin DG, Stoll B & Guan X (2003) Glucagon-like peptide
2 function in domestic animals. Domest Anim Endocrinol
24, 103–122.
94. Nian M, Gu J, Irwin DM, et al. (2002) Human glucagon gene
promoter sequences regulating tissue-specific versus nutri-
ent-regulated gene expression. Am J Physiol Regul Integr
Comp Physiol 282, R173–R183.
95. Nelson DW, Murali SG, Liu X, et al. (2008) Insulin-like
growth factor I and glucagon-like peptide-2 responses to
fasting followed by controlled or ad libitum refeeding in
rats. Am J Physiol Regul Integr Comp Physiol 294,
R1175–R1184.
96. Petersen YM, Hartmann B, Holst JJ, et al. (2003) Introduc-
tion of enteral food increases plasma GLP-2 and decreases
GLP-2 receptor mRNA abundance during pig development.
J Nutr 133, 1781–1786.
97. Macfarlane GT & Cummings JH (1991) The colonic flora,
fermentation, and large bowel digestive function. In The
Large Intestine – Physiology, Pathophysiology and Disease,
pp. 51–92 [SF Phillips, JH Pemberton and RG Shorter,
editors]. New York: Raven Press.
98. Li L, Rao JN, Guo X, et al. (2001) Polyamine depletion
stabilizes p53 resulting in inhibition of normal intestinal
epithelial cell proliferation. Am J Physiol Cell Physiol 281,
C941–C953.
99. Liu L, Li L, Rao JN, et al. (2005) Polyamine-modulated
expression of c-myc plays a critical role in stimulation of
normal intestinal epithelial cell proliferation. Am J Physiol
Cell Physiol 288, C89–C99.
100. Zhang HM, Rao JN, Guo X, et al. (2004) Akt kinase acti-
vation blocks apoptosis in intestinal epithelial cells by inhi-
biting caspase-3 after polyamine depletion. J Biol Chem
279, 22539–22547.
101. McCormack SA & Johnson LR (1991) Role of polyamines in
gastrointestinal mucosal growth. Am J Physiol Gastrointest
Liver Physiol 260, G795–G806.
102. Wang JY & Polyamines RN (2007) A stability in regulation of
intestinal mucosal growth. Amino Acids 33, 241–252.
103. Erickson RH, Gum JR Jr, Lindstrom MM, et al. (1995)
Regional expression and dietary regulation of rat small
intestinal peptide and amino acid transporter mRNAs.
Biochem Biophys Res Commun 216, 249–257.
104. Shiraga T, Miyamoto KI, Tanaka H, et al. (1999) Cellular and
molecular mechanisms of dietary regulation on rat intestinal
Hþ/peptide transporter PepT1. Gastroenterology 116,
354–362.
105. Thamotharan M, Bawani SZ, Zhou X, et al. (1998) Mechanism
of dipeptide stimulation of its own transport in a human intes-
tinal cell line. Proc Assoc Am Physicians 110, 361–368.
106. Walker D, Thwaites DT, Simmons NL, et al. (1998) Substrate
upregulation of the human small intestinal peptide trans-
porter, hPepT1. J Physiol 507, 697–706.
107. Chen H, Pan YX, Wong EA, et al. (2005) Dietary protein
level and stage of development affect expression of an
intestinal peptide transporter (cPepT1) in chickens. J Nutr
135, 193–198.
108. Ferraris RP, Diamond J & Kwan WW (1988) Dietary regu-
lation of intestinal transport of the dipeptide carnosine.
Am J Physiol Gastrointest Liver Physiol 255, G143–G150.
109. Xiao X, Wong EA & Webb KE (2004) Developmental
regulation of fructose and amino acid transporter gene
expression in the small intestine of pigs. J Dairy Sci 87,
Suppl. 1, 25.
110. Shen H, Smith DE & Brosius FC III (2001) Developmental
expression of PepT1 and PepT2 in rat small intestine,
colon, and kidney. Pediatr Res 49, 789–795.
111. Wang W, Shi C, Zhang J, et al. (2009) Molecular cloning,
distribution and ontogenetic expression of the oligopeptide
transporter PepT1 mRNA in Tibetan suckling piglets. Amino
Acids 37, 593–601.
112. Wu G, Meier SA & Knabe DA (1996) Dietary glutamine
supplementation prevents jejunal atrophy in weaned pigs.
J Nutr 126, 2578–2584.
113. Steyaert H, Tonon MC, Tong Y, et al. (1991) Distribution
and characterization of endogenous benzodiazepine recep-
tor ligand (endozepine)-like peptides in the rat gastrointes-
tinal tract. Endocrinology 129, 2101–2109.
114. Pusch W, Ja¨hner D, Spiess AN, et al. (1999) Rat endozepine-
like peptide (ELP): cDNA cloning, genomic organization
and tissue-specific expression. Gene 235, 51–57.
115. Morimoto M, Morimoto M, Zhao A, et al. (2006) Functional
importance of regional differences in localized gene
expression of receptors for IL-13 in murine gut. J Immunol
176, 491–495.
116. O’Loughlin EV, Scott RB & Gall DG (1991) Pathophysiology
of infectious diarrhea: changes in intestinal structure and
function. J Pediatr Gastroenterol Nutr 12, 5–20.
117. Agerberth B, Boman A, Andersson M, et al. (1993) Isolation
of three antibacterial peptides from pig intestine: gastric
inhibitory polypeptide(7-42), diazepam-binding inhibi-
tor(32-86) and a novel factor, peptide 3910. Eur J Biochem
216, 623–629.
118. Zarlenga DS, Dawson H, Kringel H, et al. (2004) Molecular
cloning of the swine IL-4 receptor a and IL-13 receptor 1-
chains: effects of experimental Toxoplasma gondii, Ascaris
suum and Trichuris suis infections on tissue mRNA levels.
Vet Immunol Immunopathol 101, 223–234.
119. Lalle`s JP, Bosi P, Smidt H, et al. (2007) Weaning – a chal-
lenge to gut physiologists. Livest Sci 108, 82–93.
120. Anggard E (1994) Nitric oxide: mediator, murderer, and
medicine. Lancet 343, 1199–1206.
121. Sukhotnik I, Helou H, Mogilner J, et al. (2005) Oral arginine
improves intestinal recovery following ischemia–reperfu-
sion injury in rat. Pediatr Surg Int 21, 191–196.
122. Fu TL, Zhang WT, Zhang L, et al. (2005) L-Arginine admin-
istration ameliorates serum and pulmonary cytokine
response after gut ischemia–reperfusion in immature rats.
World J Gastroenterol 11, 1070–1072.
123. Liu Y, Huang J, Hou Y, et al. (2008) Dietary arginine sup-
plementation alleviates intestinal mucosal disruption
induced by Escherichia coli lipopolysaccharide in weaned
pigs. Br J Nutr 100, 552–560.
124. Nakajima A, Wada K, Miki H, et al. (2001) Endogenous
PPARg mediates anti-inflammatory activity in murine ische-
mia–reperfusion injury. Gastroenterology 120, 460–469.
125. Sato N, Kozar RA, Zou L, et al. (2005) Peroxisome prolifera-
tor-activated receptor gmediates protection against cycloox-
ygenase-2-induced gut dysfunction in a rodent model of
mesenteric ischemia/reperfusion. Shock 24, 462–469.
126. Moraes LA, Piqueras L & Bishop-Bailey D (2006) Peroxi-
some proliferator-activated receptors and inflammation.
Pharmacol Ther 110, 371–385.
127. Calkins CM, Bensard DD, Heimbach JK, et al. (2001) L-Argi-
nine attenuates lipopolysaccharide-induced lung chemo-
kine production. Am J Physiol Lung Cell Mol Physiol 280,
L400–L408.

















128. Desreumaux P, Dubuquoy L, Nutten S, et al. (2001) Attenu-
ation of colon inflammation through activators of the reti-
noid X receptor (RXR)/peroxisome proliferator-activated
receptor g (PPARg) heterodimer: a basis for new thera-
peutic strategies. J Exp Med 193, 827–838.
129. Yasutake H, Goda T & Takase S (1995) Dietary regulation
of sucrase–isomaltase gene expression in rat jejunum.
Biochim Biophys Acta 1243, 270–276.
130. Hediger MA, Coady MJ, Ikeda TS, et al. (1987) Expression
cloning and cDNA sequencing of the Naþ/glucose
co-transporter. Nature 330, 379–381.
131. Black DD, Rohwer-Nutter PL & Davidson NO (1990) Intes-
tinal apolipoprotein A-IV gene expression in the piglet.
J Lipid Res 31, 497–505.
132. Black DD, Wang H, Hunter F, et al. (1996) Intestinal
expression of apolipoprotein A-IV and C-III is coordinately
regulated by dietary lipid in newborn swine. Biochem
Biophys Res Commun 221, 619–624.
133. Stan S, Delvin E, Lambert M, et al. (2003) Apo A-IV: an
update on regulation and physiologic functions. Biochim
Biophys Acta 1631, 177–187.
134. Lu S, Yao Y, Meng S, et al. (2002) Overexpression of apoli-
poprotein A-IV enhances lipid transport in newborn swine
intestinal epithelial cells. J Biol Chem 277, 31929–31937.
135. Mochizuki K, Mochizuki H, Kawai H, et al. (2007) Possible
role of fatty acids in milk as the regulator of the expression
of cytosolic binding proteins for fatty acids and vitamin A
through PPARa in developing rats. J Nutr Sci Vitaminol
53, 515–521.
136. Kono H, Fujii H, Asakawa M, et al. (2004) Medium-chain tri-
glycerides enhance secretory IgA expression in rat intestine
after administration of endotoxin. Am J Physiol Gastrointest
Liver Physiol 286, G1081–G1089.
137. Mayer L (1997) The role of the epithelium in mucosal
immunity. Res Immunol 148, 498–504.
138. Hontecillas R, Wannemeulher MJ, Zimmerman DR, et al.
(2002) Nutritional regulation of porcine bacterial-induced
colitis by conjugated linoleic acid. J Nutr 132, 2019–2027.
139. Bassaganya-Riera J, Reynolds K, Martino-Catt S, et al. (2004)
Activation of PPAR g and d by conjugated linoleic acid
mediates protection from experimental inflammatory
bowel disease. Gastroenterology 127, 777–791.
140. Delerive P, Fruchart J-C & Staels B (2001) Peroxisome
proliferator-activated receptors in inflammation control.
J Endocrinol 169, 453–459.
141. Levy BD, Clish CB, Schmidt B, et al. (2001) Lipid mediator
class switching during acute inflammation: signals in resol-
ution. Nat Immunol 2, 612–619.
142. Ricote M, Li AC, Willson TM, et al. (1998) The peroxisome
proliferator-activated receptor-g is a negative regulator of
macrophage activation. Nature 391, 79–82.
143. Bassaganya-Riera J & Hontecillas R (2006) CLA and n-3
PUFA differentially modulate clinical activity and colonic
PPAR-responsive gene expression in a pig model of exper-
imental IBD. Clin Nutr 25, 454–465.
144. Changhua L, Jindong Y, Defa L, et al. (2005) Conjugated
linoleic acid attenuates the production and gene expression
of proinflammatory cytokines in weaned pigs challenged
with lipopolysaccharide. J Nutr 135, 239–244.
145. Tanaka T, Kishi K, Igawa M, et al. (1998) Dietary carbo-
hydrates enhance lactase/phlorizin hydrolase gene
expression at a transcription level in rat jejunum. Biochem
J 331, 225–230.
146. Kishi K, Tanaka T, Igawa M, et al. (1999) Sucrase–isomal-
tase and hexose transporter gene expressions are coordi-
nately enhanced by dietary fructose in rat jejunum. J Nutr
129, 953–956.
147. Goda T, Yasutake H, Suzuki Y, et al. (1995) Diet-induced
changes in gene expression of lactase in rat jejunum. Am
J Physiol Gastrointest Liver Physiol 268, G1066–G1073.
148. Goda T (2000) Regulation of the expression of carbo-
hydrate digestion/absorption-related genes. Br J Nutr 84,
S245–S248.
149. Cui XL, Soteropoulos P, Tolias P, et al. (2004) Fructose-
responsive genes in the small intestine of neonatal rats.
Physiol Genomics 18, 206–217.
150. Jiang L, David ES, et al. (2001) GLUT-5 expression in neo-
natal rats: crypt–villus location and age-dependent regu-
lation. Am J Physiol Gastrointest Liver Physiol 281,
G666–G674.
151. Douard V, Cui X-L, Soteropoulos P, et al. (2008) Dexa-
methasone sensitizes the neonatal intestine to fructose
induction of intestinal fructose transporter (Slc2A5) func-
tion. Endocrinology 149, 409–423.
152. Lesage J, Blondeau B, Grino M, et al. (2001) Maternal
under-nutrition during late gestation induces fetal overex-
posure to glucocorticoids and intrauterine growth retar-
dation, and disturbs the hypothalamo–pituitary adrenal
axis in the newborn rat. Endocrinology 142, 1692–1702.
153. Tako E, Glahn RP, Welch RM, et al. (2008) Dietary inulin
affects the expression of intestinal enterocyte iron transpor-
ters, receptors and storage protein and alters the microbiota
in the pig intestine. Br J Nutr 99, 472–480.
154. Loh G, Eberhard M, Brunner RM, et al. (2006) Inulin alters
the intestinal microbiota and short-chain fatty acid concen-
trations in growing pigs regardless of their basal diet. J Nutr
136, 1198–1202.
155. Mikkelsen LL & Jensen BB (2004) Effect of fructo-oligosac-
charides and transgalacto-oligosaccharides on microbial
populations and microbial activity in the gastrointestinal
tract of piglets post-weaning. Anim Feed Sci Technol 117,
107–119.
156. Kanauchi O, Serizawa I, Araki Y, et al. (2003) Germinated
barley foodstuff, a prebiotic product, ameliorates inflam-
mation of colitis through modulation of the enteric environ-
ment. J Gastroenterol 38, 134–141.
157. Yin YL, Tang ZR, Sun ZH, et al. (2008) Effect of galacto-
mannan-oligosaccharides or chitosan supplementation on
cytoimmunity and humoral immunity in early-weaned pig-
lets. Asian-Australas J Anim Sci 21, 723–731.
158. Yang F, Wang J, Li X, et al. (2007) 2-DE and MS analysis of
interactions beween Lactobacillus fermentum I5007 and
intestinal epithelial cells. Electrophoresis 28, 4330–4339.
159. Schedle K, Pfaffl MW, Plitzner C, et al. (2008) Effect of
insoluble fibre on intestinal morphology and mRNA
expression pattern of inflammatory, cell cycle and growth
marker genes in a piglet model. Arch Anim Nutr 62,
427–438.
160. Massimino SP, McBurney MI, Field CJ, et al. (1998) Fermen-
table dietary fiber increases GLP-1 secretion and improves
glucose homeostasis despite increased intestinal glucose
transport capacity in healthy dogs. J Nutr 128, 1786–1793.
161. Cani PD, Dewever C & Delzenne NM (2004) Inulin-type
fructans modulate gastrointestinal peptides involved in
appetite regulation (glucagon-like peptide-1 and ghrelin)
in rats. Br J Nutr 92, 521–526.
162. Reimer RA & McBurney MI (1996) Dietary fiber modulates
intestinal proglucagon messenger ribonucleic acid and
postprandial secretion of glucagon-like peptide-1 and insu-
lin in rats. Endocrinology 137, 3948–3956.
163. Tappenden KA & McBurney MI (1998) Systemic short-chain
fatty acids rapidly alter gastrointestinal structure, function,
and expression of early response genes. Dig Dis Sci 43,
1526–1536.

















164. Tappenden KA, Thomson ABR, Wild GE, et al. (1996)
Short-chain fatty acids increase proglucagon and ornithine
decarboxylase messenger RNAs after intestinal resection
in rats. J Parenter Enteral Nutr 20, 357–362.
165. Tappenden KA, Drozdowski LA, Thomson AB, et al. (1998)
Short-chain fatty acid-supplemented total parenteral nutri-
tion alters intestinal structure, glucose transporter 2
(GLUT2) mRNA and protein, and proglucagon mRNA abun-
dance in normal rats. Am J Clin Nutr 68, 118–125.
166. Drozdowski LA, Dixon WT, McBurney MI, et al. (2002) Short-
chain fatty acids and total parenteral nutrition affect intestinal
gene expression. J Parenter Enteral Nutr 26, 145–150.
167. Thulesen J, Hartmann B, Nielsen C, et al. (1999) Diabetic
intestinal growth adaptation and glucagon-like peptide 2
in the rat: effects of dietary fibre. Gut 45, 672–678.
168. Thulesen J (2004) Glucagon-like peptide 2 (GLP-2), an
intestinotrophic mediator. Curr Protein Pept Sci 5, 51–65.
169. Cani PD, Neyrinck AM, Maton N, et al. (2005) Oligofructose
promotes satiety in rats fed a high-fat diet: involvement of
glucagon-like peptide-1. Obes Res 13, 1000–1007.
170. Delzenne NM, Cani PD, Daubioul C, et al. (2005) Impact of
inulin and oligofructose on gastrointestinal peptides. Br J
Nutr 93, Suppl. 1, S157–S161.
171. Leser TD & Mølbak L (2009) Better living through microbial
action: the benefits of the mammalian gastrointestinal
microbiota on the host. Environ Microbiol 11, 2194–2206.
172. Castillo M, Skene G, Roca M, et al. (2007) Application of 16S
rRNA gene-targetted fluorescence in situ hybridization and
restriction fragment length polymorphism to study porcine
microbiota along the gastrointestinal tract in response to
different sources of dietary fibre. FEMS Microbiol Ecol 59,
138–146.
173. Kozakova H, Kolinska J, Lojda Z, et al. (2006) Effect of bac-
terial monoassociation on brush-border enzyme activities
in ex-germ-free piglets: comparison of commensal and
pathogenic Escherichia coli strains. Microbes Infect 8,
2629–2639.
174. Siggers RH, Shirkey TW, Drew MD, et al. (2008) Cloning of
porcine proglucagon and effect of commensal bacteria on
relative gene expression in the intestine of gnotobiotic
pigs. Can J Anim Sci 88, 429–438.
175. Hooper LV, Wong MH, Thelin A, et al. (2001) Molecular
analysis of commensal host–microbial relationships in the
intestine. Science 291, 881–884.
176. Nerstedt A, Nilsson EC, Ohlson K, et al. (2007) Adminis-
tration of Lactobacillus evokes coordinated changes in the
intestinal expression profile of genes regulating energy
homeostasis and immune phenotype in mice. Br J Nutr
97, 1117–1127.
177. Burrin DG, Stoll B, Jiang R, et al. (2000) GLP-2 stimulates
intestinal growth in premature TPN-fed pigs by suppressing
proteolysis and apoptosis. Am J Physiol Gastrointest Liver
Physiol 279, G1249–G1256.
178. Willing BP & Van Kessel AG (2007) Enterocyte proliferation
and apoptosis in the caudal small intestine is influenced by
the composition of colonizing commensal bacteria in the
neonatal gnotobiotic pig. J Anim Sci 85, 3256–3266.
179. Mutch DM, Simmering R, Donnicola D, et al. (2004) Impact
of commensal microbiota on murine gastrointestinal tract
gene ontologies. Physiol Genomics 19, 22–31.
180. Shirkey TW, Siggers RH, Goldade BG, et al. (2006) Effects
of commensal bacteria on intestinal morphology and
expression of proinflammatory cytokines in the gnotobiotic
pig. Exp Biol Med 231, 1333–1345.
181. Chowdhury SR, King DE, Willing BP, et al. (2007) Transcrip-
tome profiling of the small intestinal epithelium in germfree
versus conventional piglets. BMC Genomics 8, 215–230.
182. Kruh J (1982) Effects of sodium butyrate, a new pharmaco-
logical agent, on cells in culture. Mol Cell Biochem 42,
65–82.
183. McCaffrey PG, Newsome DA, Fibach E, et al. (1997) Induc-
tion of g-globin by histone deacetylase inhibitors. Blood 90,
2075–2083.
184. Fusunyan RD, Quinn JJ, Fujimoto M, et al. (1999) Butyrate
switches the pattern of chemokine secretion by intestinal
epithelial cells through histone acetylation. Mol Med 5,
631–640.
185. Harig JM, Soergel KH, Komorowski RA, et al. (1989) Treat-
ment of diversion colitis with short-chain-fatty acid irriga-
tion. N Engl J Med 320, 23–28.
186. Izzo RS, Witkon K, Chen AI, et al. (1993) Neutrophil-activat-
ing peptide (interleukin-8) in colonic mucosa from
patients with Crohn’s disease. Scand J Gastroenterol 28,
296–300.
187. MacDermott RP, Sanderson IR & Reinecker HC (1998) The
central role of chemokines (chemotactic cytokines) in the
immunopathogenesis of ulcerative colitis and Crohn’s
disease. Inflamm Bowel Dis 4, 54–67.
188. Gibson P & Rosella O (1995) Interleukin 8 secretion by
colonic crypt cells in vitro: response to injury suppressed
by butyrate and enhanced in inflammatory bowel disease.
Gut 37, 536–543.
189. Segain JP, Raingeard de la Bletiere D, Bourreille A, et al.
(2000) Butyrate inhibits inflammatory responses through
NFkB inhibition: implications for Crohn’s disease. Gut 47,
397–403.
190. Zapolska-Downar D, Siennicka A, Kaczmarczyk M, et al.
(2004) Butyrate inhibits cytokine-induced VCAM-1 and
ICAM-1 expression in cultured endothelial cells: the role
of NF-kB and PPARa. J Nutr Biochem 15, 220–228.
191. Baldwin AS Jr (1996) The NF-kB and IkB proteins: new dis-
coveries and insights. Annu Rev Immunol 14, 649–683.
192. Inan MS, Rasoulpour RJ, Yin L, et al. (2000) The luminal
short-chain fatty acid butyrate modulates NF-kB activity in
a human colonic epithelial cell line. Gastroenterology 118,
724–734.
193. Weber TE & Kerr BJ (2008) Effect of sodium butyrate on
growth performance and response to lipopolysaccaride in
weanling pigs. J Anim Sci 86, 442–450.
194. Milo LA, Reardon KA & Tappenden KA (2002) Effects of
short-chain fatty acid-supplemented total parenteral nutri-
tion on intestinal pro-inflammatory cytokine abundance.
Dig Dis Sci 47, 2049–2055.
195. Zhang LT, Yao YM, Lu JQ, et al. (2007) Sodium butyrate pre-
vents lethality of severe sepsis in rats. Shock 27, 672–677.
196. Leoni F, Fossati G, Lewis EC, et al. (2005) The histone dea-
cetylase inhibitor ITF2357 reduces production of pro-
inflammatory cytokines in vitro and systemic inflammation
in vivo. Mol Med 11, 1–15.
197. Nishimura A, Fujimoto M, Oguchi S, et al. (1998) Short-
chain fatty acids regulate IGF-binding protein secretion by
intestinal epithelial cells. Am J Physiol Endocrinol Metab
275, E55–E63.
198. Lund PK & Zimmermann EM (1996) Insulin-like growth
factors and inflammatory bowel disease. Baillieres Clin
Gastroenterol 10, 83–96.
199. Wild GE, Searles LE, Koski KG, et al. (2007) Oral polyamine
administration modifies the ontogeny of hexose transporter
gene expression in the postnatal rat intestine. Am J Physiol
Gastrointest Liver Physiol 293, G453–G460.
200. Blachier F, Mariotti F, Huneau JF, et al. (2007) Effects of
amino acid-derived luminal metabolites on the colonic
epithelium and physiopathological consequences. Amino
Acids 33, 547–562.

















201. Motyl T, Ploszaj T, Wojtasik A, et al. (1995) Polyamines in
cow’s and sow’s milk. Comp Biochem Physiol B Biochem
Mol Biol 111, 427–433.
202. Schultz SG & Hudson RL (1991) Biology of sodium-absorb-
ing epithelial cells: dawning of a new era. In Handbook of
Physiology. The Gastrointestinal System. Intestinal Absorp-
tion and Secretion, vol. IV, 2nd ed., pp. 45–81 [M Field
and RA Frizzell, editors]. Bethesda, MD: American Physio-
logical Society.
203. Luk GD, Marton LJ & Baylin SB (1980) Ornithine decarbox-
ylase is important in intestinal mucosal maturation and
recovery from injury in rats. Science 210, 195–198.
204. Chen J, Rao JN, Zou T, et al. (2007) Polyamines are required
for expression of Toll-like receptor 2 modulating intestinal
epithelial barrier integrity. Am J Physiol Gastrointest Liver
Physiol 293, G568–G576.
205. Abreu MT, Fukata M & Arditi M (2005) TLR signaling in the
gut in health and disease. J Immunol 174, 4453–4460.
206. Janeway CA Jr & Medzhitov R (2002) Innate immune recog-
nition. Annu Rev Immunol 20, 197–216.
207. Cassar-Malek I, Picard B, Bernard C, et al. (2008) Appli-
cation of gene expression studies in livestock production
systems: a European perspective. Aust J Exp Agric 48,
701–710.
208. D’Haeseleer P (2005) How does gene expression clustering
work? Nat Biotechnol 23, 1499–1501.
209. Hamard A, Mazurais D, Boudry G, et al. (2007) Physiologi-
cal aspects and ileal gene expression profile of early-
weaned piglets fed a low threonine diet. Livest Sci 108,
17–19.
210. Marion J, Biernat M, Thomas F, et al. (2002) Small intestine
growth and morphometry in piglets weaned at 7 days of
age, effect of level of energy intake. Reprod Nutr Dev 42,
339–354.
211. Jansman AJM, Niewold TA & Hulst MM (2007) Inclusion of
linseed and linseed expeller meal in piglet diets affects
intestinal gene expression profiles. Livest Sci 108, 23–25.
212. James PS, Smith MW, Tivey DR, et al. (1987) Epidermal
growth factor selectively increases maltase and sucrase activi-
ties in neonatal piglet intestine. J Physiol 393, 583–594.
213. Collins J, Starkey WG, Wallis TS, et al. (1988) Intestinal
enzyme profiles in normal and rotavirus-infected mice.
J Pediatr Gastroenterol Nutr 7, 264–272.
214. Lifschitz CH, Smith EO & Garza C (1983) Delayed complete
functional lactase sufficiency in breast-fed infants. J Pediatr
Gastroenterol Nutr 2, 478–482.
215. Boudry G, Lalle`s JP, Malbert CH, et al. (2002) Diet-related
adaptation of the small intestine at weaning in pigs is func-
tional rather than structural. J Pediatr Gastroenterol Nutr
34, 180–187.
216. Thacker PA (1999) Nutritional requirements of early
weaned pigs: a review. Pig News Info 20, 13N–24N.
217. Brooks PH, Moran CA, Beal JD, et al. (2001) Liquid feeding
for the young piglet. In The Weaner Pig: Nutrition and
Management, pp. 153–178 [MA Varley and J Wiseman,
editors]. Wallingford: CAB International.
218. Van Dijk AJ, Everts H, Nabuurs NJA, et al. (2001) Growth
performance of weaned pigs fed spray-dried animal
plasma: a review. Livest Prod Sci 68, 263–274.
219. Spreeuwenberg MAM, Verdonk JMAJ, Gaskins HR, et al.
(2001) Small intestine epithelial barrier function is compro-
mised in pigs with low feed intake at weaning. J Nutr 131,
1520–1527.
220. Sanderson IR & Naik S (2000) Dietary regulation of intesti-
nal gene expression. Annu Rev Nutr 20, 311–338.
221. Stierum R, Burgemeister R, van Helvoort A, et al. (2001)
Functional food ingredients against colorectal cancer. An
example project integrating functional genomics, nutrition
and health. Nutr Metab Cardiovasc Dis 11, Suppl., 94–98.
222. Reimer RA, Thomson ABR, Rajotte RV, et al. (1997) A phys-
iological level of rhubarb fiber increases proglucagon gene
expression and modulates intestinal glucose uptake in rats.
J Nutr 127, 1923–1928.
223. Ogawa H, Rafiee P, Fisher PJ, et al. (2003) Butyrate modulates
gene and protein expression in human intestinal endothelial
cells. Biochem Biophys Res Commun 309, 512–519.
224. Fusunyan RD, Quinn JJ, Ohno Y, et al. (1998) Butyrate
enhances interleukin (IL)-8 secretion by intestinal epithelial
cells in response to IL-1[beta] and lipopolysaccharide 1.
Pediatr Res 43, 84–90.
Intestinal gene expression in pigs 175
N
u
tr
it
io
n
R
es
ea
rc
h
R
ev
ie
w
s
